POPULARITY
3 episodes with chariman
2 episodes with chariman
2 episodes with chariman
2 episodes with chariman
2 episodes with chariman
2 episodes with chariman
(00:00-30:12) NFL Hall of Famer, Issac Bruce joins the show. The Issac Bruce Foundation and Flight 300. Rams moving here around this time 30 years ago. Blocking punts and playing special teams early in his career. Torry Holt still waiting for the call from the Pro Football Hall of Fame. What's he up to these days? Rooting for Anthony Edwards in the NBA playoffs. Playing basketball back in the day. Mt. Rushmore of St. Louis Rams. Janoris Jenkins's Doo Doo Man of the Week.(30:21-46:07) Hearing this has Doug ready to get in his car and drive. Tim was conceived in a hotel room in Boston. Chariman is going to check it out this weekend. Getting booted off the air for making masturbatorial references. Chairman got bait and switched to have the bill of his new hat bent. Tim's son wanted to watch Goodwill Hunting. How 'bout that Minnie Driver, eh? Kids and curse words.(46:17-54:46) The juxtaposition of it all. An emotional smoothie. Doc Hollywood. Doogie Howser. Driving to eighth grade. Neil Patrick Harris broke through the glass ceiling.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Noel Culleton, Chairman of the Wexford Parish Care for the Earth Group. This group has led sustainability efforts in Wexford, from hosting a Climate Action conference to planting over 1,000 trees and promoting climate justice.
Malcolm Holland, Chariman of the Board, CEO and President of Veritex Community Bank, sees himself as a banker who embraces opportunities.On today's show, Al and Steve chat with Malcolm about how he started a bank as a 25-year-old in the 1980s – a turbulent period for banking – and how his experience of bad times helped shape his career in making big leaps; arguably, none bigger than founding his current bank at age 49 by using the inheritance money left to his wife... with her blessing.Malcolm chats with the guys about the importance of using data to make decisions, the art of nurturing or replacing talent and what's next for the bank. Malcolm also talks about the bank's women in small business initiative. As he says: "I love it."
(00:00-14:54) Struggling this morning after a great Christmas Party at Hotshots last night. Doug had to dodge a lot of kisses last night. Martin says Ray King was a "Handsome Trucker." O'Fallon seems to be ripe with Furries. Women born in the late 90's were out in full force last night. Jackson has an official statement. Big thanks to everyone who made the Christmas Party and Toy Drive so great last night.(14:55-26:52) Bif got Chariman's personal phone number last night. Rough night for The Note against the Sharks last night. Blues seem to enjoy giving up goals right after they score one themselves. Audio of Jim Montgomery talking about the boys' performance last night.(26:53-46:29) Big prizes today for the EMOTD. Bleacher Report's Top 25 North American Most Insatiable Sports Franchises of the last 25 years. Doug really wants the Braves to be on that list. The backlash of Jackson's End of the Year Award Nominees. Our programs is a peep show. Run back Purna.(46:30-1:07:40) Belichick turned on the charm yesterday. Audio from his press conference at UNC yesterday. Buy out if he leaves. Stephen A Smith and Molly Qerim got into it. Caller Adam who was NOT nominated for Caller of the Year is on the lines to complain. Update on his circumcision. Implied Ladue Power. Handsome Trucker, Ray King chiming in with thoughts from last night. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
(00:00-14:54) Struggling this morning after a great Christmas Party at Hotshots last night. Doug had to dodge a lot of kisses last night. Martin says Ray King was a "Handsome Trucker." O'Fallon seems to be ripe with Furries. Women born in the late 90's were out in full force last night. Jackson has an official statement. Big thanks to everyone who made the Christmas Party and Toy Drive so great last night. (14:55-26:52) Bif got Chariman's personal phone number last night. Rough night for The Note against the Sharks last night. Blues seem to enjoy giving up goals right after they score one themselves. Audio of Jim Montgomery talking about the boys' performance last night. (26:53-46:29) Big prizes today for the EMOTD. Bleacher Report's Top 25 North American Most Insatiable Sports Franchises of the last 25 years. Doug really wants the Braves to be on that list. The backlash of Jackson's End of the Year Award Nominees. Our programs is a peep show. Run back Purna. (46:30-1:07:40) Belichick turned on the charm yesterday. Audio from his press conference at UNC yesterday. Buy out if he leaves. Stephen A Smith and Molly Qerim got into it. Caller Adam who was NOT nominated for Caller of the Year is on the lines to complain. Update on his circumcision. Implied Ladue Power. Handsome Trucker, Ray King chiming in with thoughts from last night. Learn more about your ad choices. Visit podcastchoices.com/adchoices
4p - Matt Marcovich on the EV rebate fund // Elon Musk Awards $1 MILLION Check to Random Audience Member at Pennsylvania Event — Pledges to Give Away $1 Million Per Day to a Signer of His Petition // Walz says Elon Musk is Trump’s running mate; calls him a “dips@!t” // Election 2024 - 13.5 days until election day // Guest - Jim Walsh - State Rep and Chariman of the WA State Republican Party // Where we stand on the initiatives and election integrity lawsuits in Washington // ‘De-Extinction’ Company Says It’s Very, Very Close to a Complete Tasmanian Tiger Genome.
They're up and waiting for us in the YouTube chat. Reliving the Jason Smith and Greg Robinson draft picks. Iggy's down on the Cardinals using publications to scout players. Sadie Hawkins, Doug, what's the lede? Justin Thomas is in the clubhouse leading The Open. Doug is greeting card folksy. Choice weather. Nelly is a fan of the show and started following our IG. Tim reads his latest DM, and not to be one-upped, Iggy does too. College Football projections based on some guy's 25 simulated seasons. Chariman's virtual Tigers had a big night last night. Brady Cook and KSDK. Someone emailed Tim Sepp Straka driving data. Learn more about your ad choices. Visit megaphone.fm/adchoices
They're up and waiting for us in the YouTube chat. Reliving the Jason Smith and Greg Robinson draft picks. Iggy's down on the Cardinals using publications to scout players. Sadie Hawkins, Doug, what's the lede? Justin Thomas is in the clubhouse leading The Open. Doug is greeting card folksy. Choice weather. Nelly is a fan of the show and started following our IG. Tim reads his latest DM, and not to be one-upped, Iggy does too. College Football projections based on some guy's 25 simulated seasons. Chariman's virtual Tigers had a big night last night. Brady Cook and KSDK. Someone emailed Tim Sepp Straka driving data. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Big weekend in St. Louis sports so time to dive right in. Kakaw clinched a playoff berth. Doug takes down the DFS Showdown: PGA Championship edition and has won FIVE in a row. The NL Central, how bout that whole deal? The PlowBurke coming in HOT with scorching Cardinals takes. Audio of John Mozeliak on KSDK talking who could come up from the minors to make an impact, players who have gotten away, the television situation, job security, and Trevor Bauer. Jordan Walker's power struggles. We have a situation in the Chariman Kurt/Mr. Lix Round of 32 matchup in the FPCC. The City Connect jerseys have been released. Back to LIx and KG. Should an extension be granted? Mr. Lix on the line to talk about it. The Chariman has reached his decision. Learn more about your ad choices. Visit podcastchoices.com/adchoicesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Big weekend in St. Louis sports so time to dive right in. Kakaw clinched a playoff berth. Doug takes down the DFS Showdown: PGA Championship edition and has won FIVE in a row. The NL Central, how bout that whole deal? The PlowBurke coming in HOT with scorching Cardinals takes. Audio of John Mozeliak on KSDK talking who could come up from the minors to make an impact, players who have gotten away, the television situation, job security, and Trevor Bauer. Jordan Walker's power struggles. We have a situation in the Chariman Kurt/Mr. Lix Round of 32 matchup in the FPCC. The City Connect jerseys have been released. Back to LIx and KG. Should an extension be granted? Mr. Lix on the line to talk about it. The Chariman has reached his decision. Learn more about your ad choices. Visit megaphone.fm/adchoices
Rabbi Shlomo Litvin, the Chariman of the Kentucky Jewish Council, discusses KET giving voice to anti-Jewish political candidates, on-campus protests at the University of Kentucky, the globalizing of intifada, and the release of hostages being held by Hamas...
We talk Leadership on this edition of the SPOTLIGHT WITH JEFF SHANNON. We speak with the Exec. Director with Leadership Middle Tn and The Chariman of the Board with Habitat Humanity of Sumner County, Michael Lajoie.
In today's live edition of the Trish Regan Show, Trish reports on JP Morgan's prediction that Joe Biden will drop out of the Presidential 2024 race due to 'health' issues. According to Michael Cembalest, Chariman of Market and Investment Strategy for JP Morgan Assets & Wealth Management, "President Biden withdraws sometime between Super Tuesday and the November election, citing health reasons. Biden passes the torch," he writes, "to a replacement candidate named by the Democratic National Committee." SUBSCRIBE to my YOUTUBE for daily videos from the Trish Regan Show Subscribe to my whole audio show on Apple Podcasts: https://apple.co/3ZHdJOk Check out my Live Free merch! https://trishregan.shop/ Follow me on: Instagram: https://www.instagram.com/trish_regan/ Twitter: https://twitter.com/trish_regan Facebook: https://www.facebook.com/RealTrishReganSupport the show: https://trishregan.shop/See omnystudio.com/listener for privacy information.
Lior Tal is CEO and Chariman of Cyngn, a Silicon Valley-based technology company that develops and deploys scalable, differentiated autonomous vehicle solutions to industrial fleets. Key topics in this conversation include: Introduction and Background Identifying the Opportunity in Industrial Autonomy Designing a System for Industrial Applications Choosing the Right Applications to Develop The Complexity of Industrial Autonomy Adopting Industrial Autonomy in Different Industries Current Focus and Demand in Manufacturing and Logistics Approach to Manufacturing and Supply Chain Managing Time and Bringing in the Right Expertise Balancing Roles and Self-Awareness as a CEO The Potential of DriveMod as a Platform Links: Show notes: http://brandonbartneck.com/futureofmobility/prescottwatson LinkedIn link: https://www.linkedin.com/in/liortal/ Check out the Cyngn Website: https://www.cyngn.com/ Follow Cyngn on LinkedIn: https://www.linkedin.com/company/cyngn Follow Cyngn on Twitter: https://twitter.com/cyngn About Lior Tal: Lior Tal has served as Cyngn's CEO and a Chairman since 2016. Prior to joining, Lior was the director of international growth and partnerships at Facebook for five years. He also has previous executive experience as cofounder of Snaptu, which was later acquired by Facebook. Here, he helped grow the user base from launch to tens of millions of users over a two-year period. Prior, Lior was a partner at Barzam, Tal, Lerer Attorneys at law & Patent attorneys for three years, and further held leadership roles at Actimize (acquired by NICE), DiskSites (acquired by EMC), and Odigo (acquired by Comverse). Company Overview Cyngn (NASDAQ: CYN) is a Silicon Valley-based technology company that develops and deploys scalable, differentiated autonomous vehicle solutions to industrial fleets. Cyngn's self-driving solutions help industrial organizations become more efficient, productive, and safe, addressing challenges such as labor shortages, safety incidents, and increased demand. Cyngn has been operating autonomous vehicles in production environments since 2017. Future of Mobility: The Future of Mobility podcast is focused on the development and implementation of safe, sustainable, effective, and accessible mobility solutions, with a spotlight on the people and technology advancing these fields. linkedin.com/in/brandonbartneck/ brandonbartneck.com/futureofmobility/ Edison Manufacturing and Engineering: Edison manufacturing is your low volume contract manufacturing partner, focused on assembly of complex mobility and energy products that don't neatly fit within traditional high-volume production methods.
My guest this week is Belgian nurseryman Karel Goossens. Karel runs an internationally renowned nursery supplying box plants and is the Chariman of the Belgian arm of the European Boxwood & Topiary Society. With decades of experience growing box and an irreverent approach to tackling the problems that go along with it, when he was recommended to me, I thought he was my ideal sort of guest! He does recommend intensive cultivation methods which include spraying chemical fungicides and insecticides, so this epsiode is not for everyone. However, I do acknowledge that many historic gardens are built around a backbone of box and that many listeners are professional gardeners who deal with box and its attendant blights, so this epsiode is a practical look at what you can do. Dr Ian Bedford's Bug of the Week: Box Tree Moth Links Kwekerij Goossens on Instagram European Boxwood & Topiary Society Karel's website for tripod ladders Our Plant Stories with Sally Flatman Other episodes if you liked this one: Lawns with David Hedges-Gower Hiring a Garden Designer
https://chtbl.com/track/118312/traffic.libsyn.com/secure/talkinglead/511_Buckmaster_2_CDK.mp3 In this episode of the Talking Lead Podcast: We talk about the rebirth of the old Buck Knives' Buckmaster model 184 and 185 to the new Buckmaster Combat Dive Knife Pro (CDP) model 084. Nearly 40 years have past since the first Buckmaster hit the market which was made insanely popular by the Rambo: First Blood movie. Joining Lefty to talk about the history of the Buckmaster and the development of the CDP are: CJ Buck, CEO and Chariman of Buck Knives; Richard Neyman, Historian, Author and Developer: Commander DT Coulter, "SEAL" United States Navy Retired and Developer. Commander Coulter's 55 year journey to finding the Ultimate Dive Knife has led to the development and production of the new Buckmaster 2.0 Combat Diver model 084.
The first of a three-part journey into Chianti Classico. in this episode we look at the past, present and future of the denominazione with our special guest, Giovanni Manetti, Chariman of the Chianti Classico Consorzio and proprietor of the venerated Fontodi estate in Panzano. This is Manetti's second term as the Chairman , where he has been a driving force of innovation and evolution, helping to re-establish Chianti Classico as one of Italy's, and the world's, leading quality wine-producing regions. The creation of the Gran Selezione category at the top of the quality pyramid, as well the introduction of UGAs (Unità Geografiche Aggiuntivi), added geographic mentions within the greater Chianti Classico territory, are just two of the invigorating projects which Manetti has championed and pushed through.The Thieves deliver the latest news regarding Gran Selezione regulations and the new UGAs, but focus first on the history of the region from Etruscan settlements in the 8th century BC, to the legend of the gallo nero, the mezzadria sharecropping system that shaped Chianti Classico as we know it today, Barone Ricasoli's 19th century 'recipe' for Chianti, the 1970s crisis (fiasco?), and the renaissance of quality wine. There is much to unpack in this multi-faceted region, so important and recognizable to wine lovers around the world.A happy 307th birthday to Chianti Classico, an anniversary for which we give thanks to the Grand Duke of Tuscany and patron to the arts, Cosimo dei' Medici III, who famously demarcated the wine region of Chianti in 1716 and created the first legal appellation of origin for wine in the world. Tuscan aficionados won't want to miss this episode that reveals how Chianti Classico's past has set the stage for its modern renaissance. This episode has been produced in partnership with the Chianti Classico Consorzio and financed according to EU regulation 1308/2013.
From Oliver Anthony to Governor Youngkin, he was one of the most popular people at the 2024 GOP Presidential Debate (that WASN'T on the stage) and Rich Anderson tells us what it was like.See omnystudio.com/listener for privacy information.
JUCO World Series Chairman Jamie Hamilton on The Jim Davis Show.
Former Courier Journal and Louisville Times writer Bob Hill joined David Jones Junior, the former Chariman of the Board at Humana, in the studio to tell stories about and discuss a new book on David Jones Senior called "Always Moving Forward"...
Watch this conversation on YouTube- https://youtu.be/uA3zc2_os3s You'll learn: Why saying I want to be healthy is a wrong question? Why do people stop going to the gym after a few weeks? How to drive habit changes using a framework? How the biopsychosocial approach helps in understanding health and illness? What is Circadian Rhythm and what role does it play in our health and longevity? How can you become disciplined with your habits? Shiva Subramanian, Founder and Chariman of the Connect Venture Group of companies, is one of India's foremost impact and sustainability enterpreneurs. He is an International Management and Finance graduate from United World College of SEA and Nottingham University (U.K). His vision behind transforming health and sustainability in India is to bridge the gap between Health and the Environment by creating an expertise rich corporate ecosystem to observe, research and develop the interrelations and connections between the two. This has enabled him to build great products and companies and being a mentor-leader of great teams. What makes his companies successful are the impactful solutions they provide and the possibilities that lie in the future. We have a telegram community for our listeners. Join here- https://theinspiringtalk.com/telegram For brand collaborations and opportunities, send us an email at hi@wyn.studio Read full episode notes at https://theinspiringtalk.com/ Send me a voice message: https://theinspiringtalk.com/speak Connect with Shiva Subramanian Website LinkedIn Follow the Inspiring Talk on Facebook http://theinspiringtalk.com/facebook Twitter http://theinspiringtalk.com/twitter Instagram http://theinspiringtalk.com/instagram
Ok. We all know that there are a ton of benefits to working out and eating healthy, especially as Father Time starts to kick our ass. We can't expect to live longer, healthier lives if we're sitting on the couch with a 12-pack and a bag of Doritos by our side. If we want to really kick some ass on the pickleball court, rock somebody's world in the bedroom, and feel good overall - we're going to need to get serious about our health and fitness. In this episode, we talk to a true Over 50 Badass, Scott Jagodzinski. Scott Jagodzinski is the founder of Argent Alpha, a program and community making Men over 50 Harder to Kill. Scott is also a co-founder and Chariman of Alchemy365, a boutique fitness studio with 8 locations (soon to be 9) in two states. Prior to joining the health and wellness industry, Scott was CEO at two different companies, leading one of them in an exit to a public company. Scott currently splits his time between MN and AZ, is happily married to his high school sweetheart and has 3 adult children and one grandson. Scott is a Badass Thought Leader and regular contributor to Over 50 Badass. Check out Scott on LinkedIn - https://www.linkedin.com/in/jagodzinski/
00:00 - Introduction 03:50 - Career History 12:32 - Building teams, Building Companies 17:02 - Mining is a long term investment 21:54 - The Mining Cycles 25:22 - Responsible Mining 28:41 - Ewoyaa Lithium Project 33:40 - A Commodiy demand never before seen in a lifetime 39:33 - Atlantic Lithium Roadmap 43:28 - Time at Premier African Minerals 46:27 - Final Thoughts & Goals for 2023
Phil Reynolds is the Co-founder and CEO of DevStride, an Enterprise Agile Planning tool that frees your team from project silos. DevStride raised a $3.3m pre-seed round in August of 2022 following 18 months of initial product development.Prior to DevStride, Phil was the Co-founder and CEO of BriteCore where he continues to serve as Chariman. BriteCore is a leading administration system for Property Casualty insurance that grew from a $6.1m seed-stage valuation in 2011 to a $180m Series B valuation in 2019.Phil is a frequent speaker and presenter and has been featured in numerous national publications. He has placed repeatedly in the the Inc 500, been named Missouri Governor's Entrepreneur of the Year. He has obtained certifications for Scaled Agile Leadership,Property Casualty Underwriting, and Leading Change in Complex Organizations through MIT's Sloan School of Management. He is also a member of the Acrew Capital Crew of Leaders, and an active LP in the First Close Partners Network.He is an avid fan of technology, music, whiskey, and car who enjoys mentoring first time founders whenever possible.Connect with Behind Company Lines and HireOtter Website Facebook Twitter LinkedIn:Behind Company LinesHireOtter Instagram Buzzsprout
Voice Of Youth_Arjun Subedi_Nakshatra Foundation Chariman-social Worker --- Send in a voice message: https://anchor.fm/radio-candid/message
This episode is for those looking for ways to deal with rejection. Denny Hammack is the Chariman of Patterson Pope - but on this episode he shares the rocky beginning he had to his career and how he was able to overcome seeming “failures” throughout his education to eventually become successful in his relationships and business. Topics Covered06:42 - Denny shares how he was rejected on almost every job application he put in out of college. 11:03 - The story of Denny's disastrous apparel choice on his first date with his now-wife. 21:09 - How Denny thinks about the different stages of life: success and significance 27:12 - When Denny finally realized that he was on the right path to success 36:33 - The reason Denny decided to try a new career during a “midlife” crisis at 28 48:43 - Challenges that Denny has faced leading a large organization Connect with Dennyhttps://www.whatsnextministry.org/ (What's Next Ministry) https://www.linkedin.com/in/denny-hammack-9a1a905/ (LinkedIn) Resources Mentionedhttps://www.amazon.com/Halftime-Significance-Bob-P-Buford/dp/0310344441 (Halftime: Moving from Success to Significance)
Joseph Gitler, Founder and Chariman of Leket Israel
This was supposed to be a bonus episode but the news is too big! Vince steps down as Chariman of WWE, Stephanie steps up. Tullo discusses why he is happy to see Vince go. Dan breaks down the negative vibes WWE has given him over the years. Christina twerks hahahahah! Patreon.com/comediansofwrestling Video: https://youtu.be/rb0w7IYwD9g
Episode Summary:Elon Musk Sells $5 Billion of Tesla Shares$500 Shiba Inu Giveaway Guests:Ben Rabizadeh StoryTrading 10:00Vivi Biotech Queen https://twitter.com/Biotech_SD 24:00Zandy Forbes, Ph.D. President & CEO of MeiraGTx (NASDAQ: MGTX) 41:00Ronen Samuel, CEO of Kornit (KRNT) 55:00Scott Mathis, CEO and Chariman of Guacho Holdings $VINO 70:00Renato Capelj, Benzinga, Physik Invest 110:00https://physikinvest.com/Hosts:Spencer IsraelTwitter: https://twitter.com/sjisraelAaaron BryTwitter: https://twitter.com/aaronbry5Subscribe to all Benzinga Podcasts hereClick here for BENZINGA TRADING SCHOOL Get 20% off Benzinga PRO here Become a BENZINGA AFFILIATE and earn 30% on new subscriptionsDisclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Unedited Transcriptwe got a lot of guests today. Here's that's what I said. Here's what we got. We got Ben from story trading in like eight minutes. We've got Vivi biotech, uh, or the Bio-Queen at, uh, 1215. We've got Zandi Forbes from Mira GTX. She's a presidency yet.We're talking gene editing at 1230. We got Ronan Senor from Coronet digital we're talking, uh, fashion and the fashion supply chain at 1245. Did I get all that right? As far as timing goes. Yep. We got Scott Mathis from Gaucho holding sicker V I know, uh, at one and that Renato, uh, Capella, he is a Benzinger writer and also does some really, really cool options trading on the side.Uh, he'll be on the show at one 30. So we got what we got. 1, 2, 3, we got six guests today. We have all that's a lot, frankly. Uh, maybe a few too many, but nonetheless, here we are. So before we get to those guests, uh, we're going to talk about what's what's moving. We're going to talk about, uh, crypto. We're going to do a guest that sharp sediment.Cause we got some good feedback from that yesterday. So, um, AB where should we start? Um, well, let's start with just looking at the overall market. Spencer. I see Christian in the chat asking who do we have on for a guest today? You just ran through them, but you can also check the description in the YouTube, uh, the YouTube description for the guests for the day.Um, and shout out to the chat yesterday. We had some good trade ideas thrown out in the chat yesterday. We did, uh, easy Mike was talking about Uber puts. I played those. They were up nicely. Um, and we were talking about playing Disney for a big move on either side. We got talked out of it by our main man, Nick Shaheen.But yeah, I don't know. Maybe we should have done it. Yeah. I felt bad about that one going and they got talked out of it, but, uh, you know, it was a pretty brutal quarter. So, um, anyway, I don't even know why I look at Disney it's in my never sell portfolio. That's my first mistake is don't look at and stuff and your never sell portfolio.Otherwise you're just giving yourself anxiety. Rowan DAS pips is saying audio levels. Are we good, Bruce? Or Ron? Are you awake? I'm here. Okay. Oh, he's coming through us through the sky. I did not know that was coming from Terminator. I'm hanging out on the background, like a good idea. Hey, uh, while we figure out those levels, if you all want to do a solid, as DK suggested and hit that like button ladies and gentlemen, we'd appreciate that.Thank you very much. Um, Hey, what's do a guest, that chart segment. We're going to start doing this every day yesterday. Wasn't it easy one a B I don't even remember what it was. It was D whack. Oh yeah. That was that. That was yours. Full disclosure, I guess the one today. No, because I changed it. Shoot. So beforehand Spencer showed me the guests that chart and I guessed it and he didn't like the fact that I got it so easily.So he went out and picked a new one. I don't know what it is. I went out and I picked her from, Ooh, this will be a good drawer. And then he gets to like right away. So it's not a firms that don't get that, um, drop your answers on the chat and whoever's right. Uh, email us afterwards and we'll send you some swag.Um, here is two days chart of the day. This is going back to like February, or actually this is going back to the start of the year. This is going back to the interests of the start of the year. Now I will give you some hints because otherwise it'd be impossible. I feel like, um, in some respects, this is a technology stock in some respects.Oh man, we can have a winner already. Holy moly. Christian Gallagher. Wait, it was PayPal. This is PayPal. How so are we looking at weekly candles right now? Is this a daily PayPal has gotten beat up over the past month or so it looks like, yes, it has gotten beat up is, is, is, is a nice way of putting it, but yes, Christian Gallagher.Did anyone yesterday? No, Frendo on yesterday. Christian email us shows app benzinga.com. Hey, why is PayPal down so much? Didn't they just announce a Venmo, Amazon integration. So yeah, you would think that tell me you don't own PayPal or maybe you do and you don't know it. Um, I think in my like real portfolio, the one that I don't manage it's in there scourge.It's too easy with showing prices. Well, that's an idea. I take the price off ridiculously hard, but we could do that. Should I buy? I like calls on PayPal. No, it's gotta be coming back up at some point, right? That's one way of putting it. Um, you want to throw out like, uh, you know, you want to buy the, the, the, the, the two 80 strikes expiring and like six months.Really worth looking at. I'm sure it's not very much money. I do think though we have to, um, you know, keep up, like if we start doing obscure biotech stocks, you know, it'd be nearly impossible. So what we'll probably try to stick to, I dunno, S and P 500. Yeah. That's, that's, that's a good plan. Stick to the S and P 500.So we're going to do this everyday. Christian email us shows up and it's going to come. We will hook you up with some schwag before we go to our first guest AB I seem working backstage. Let's do our first crypto update of the day. Sure. Yeah. So yesterday Bitcoin spiked on the CPI data and then gave up all those gains and more.Let's take a look today to see how the, the crypto markets are responding to that yesterday. Uh, we, we have a lot of people in the chat that have been asking kind of how are they supposed to be trading crypto right now? So I know you and I, Spencer are in that boat where we're just like adding Ethereum and not really touching it or selling it.I haven't even added recently. It's been a while for me. I hadn't bought a theorem. I wanted the board. So yesterday, w like I've mentioned, once that CPI data came out, Bitcoin spiked and actually hit brand new, all time highs, um, gave all those gains up is currently trading about $65,000 a coin down 4.8%.Ethereum is also down, albeit not as much Ethereum currently, right around $4,800. So we talked about that $5,000 level being a big level for Ethereum. I think once we see a theory and finally breakthrough that $5,000 level, we can really see it run. Um, but yeah, everything pretty much in the red, like you can see from this heat map Sheba, he knew though in the green up 5%, um, we're actually going to have a big Shiba Inu guest on the show tomorrow.Uh, his name is Ross. He was an early investor and also a kind of co-developer of Sheba. So he's someone that I think I can say confidently knows more about Shiba Inu than 99.9% of people in the world. Um, so if you're interested in Sheba or what's next for the coin tune in tomorrow, he'll be on about one 30, uh, Spencer, any thoughts on this crypto heat map?I I'm trying to get a link right now because we're actually doing a sheep giveaway. I'm trying to get the link for that. I don't have it handy, but we're giving away some free shipping. I hope somebody gets me that link so I can get it to you. Uh, that's my thought, my thought is no. I mean, Bitcoin is an inflation hit crypto isn't inflation, hedge.Um, I don't quite understand the why it's down like this today, but you don't. All you need to do is look at the reaction to Bitcoin at 8:30 AM. Eastern time yesterday, right? Inflation comes out. It's harder than expected. It's it's more than expected. What does Bitcoin do? It goes up. Mike is saying, Hey, be it.It's a good play. Definitely go for PayPal options. Um, so I don't know if he's, you know, facetiously saying that he wants to see me lose some money, but I'm looking at him. I'm looking at the calls. Um, but yeah, Spencer, like you mentioned get some free Bitcoin we'll we'll throw that zing token up real quick.Go to Voyager. You put in a hundred dollars, you get $50 free Bitcoin, if you use the code zing. Uh, so not a bad deal at all. I mean, who doesn't want $50 of free Bitcoin checkout Voyager for that? Use the code zing. Um, all right. Real quick before we get to Ben. Yeah. Yeah. And, and I'm going to post the link to the ship giveaway.Um, when I, once you find that I find it. Yeah, no problem. Somewhere out there, easy Mick, you might be the guy who knows technicals what they're talking about when it comes to technicals, I'm watching a. Dash, which has been up a lot over the past, I don't know, week or so. Is this, is this, this the kind of subtle head and shoulders forming on the, on the one day chart?I think we're looking at five minute candles right here. I see one shoulder here. This could be the head, if this is the, the second shoulder, um, you know, could it start falling down or should I be looking at some dash puts, I need someone who knows technicals better than I do to let me know if this is, uh, you know, I'm not a big patterns guy, so I'm not really know, but we have some people out there that are outsourcing.And I know, I know when I need to listen to someone that knows more than I do. Yeah. Um, Alvin say, and he's looking at Wayfair puts an ADSL. K what's ADSL desk. Autodesk. Yeah, by the way, I just put the link in the chat for the ship giveaway. There it is. There it is. You can't click it on the screen, but it's in the chat.I'm just throwing up there. So y'all know it is there. All right. Y'all so story train. If you guys have watched a show before you've seen Ben on the show, he gave us a E H R at, I don't know, four bucks, three bucks. What does it now? It's like, I like 20 let's check real quick before he comes on. He'll give us an update on AHR.Um, it's at $23. So let's see. I mean, it's, it's up. I want to say like at least 200% since he pitched us to us on the show, he's got a couple more stocks. We're going to talk about, uh, Should we bring them on easy MC RSI? Isn't it. If the RSA is 90, isn't that a sign it could come to? I don't know. You, you know, more about technicals than I do.Let me know. All right. Without further ado, let's go ahead and get BenOh, Ben, what was the, what was the price of AHR when you first came on the calendar? What's up guys? Yeah. When I first came on, the show was around $5, five 40, somewhere that somewhere in the low fives, I believe it was. Yeah. And when we first presented it to our VIP community, when I presented as a trade idea, it was $2 and 74 cents.What, all the way up to 27. So it was a 10 bagger if you captured that. And I happened to pretty much captured that I was done. I'm handing this from 2 74. I didn't sell my first shares until 16. And then, um, I sold a lot more in the, in the 20 to 25, 26 weeks and maybe even gotten a little bit at 27. So, um, yeah, I've got a few updates for you on, on that.And a couple other sucks. Yeah. You got a new background. This is the first time we're seeing this. It looks pretty good. Yeah. A lot more work to do. We got to get that our mikes and cameras and everything, but yeah, this is the first time anyone's seen this background. Cool. And you said too, it looks like we did.It took us far too long, but we eventually got it together. You get a zoom out so Ben can see our beautiful. Oh, wow. That's great, man. Um, all right, Ben, you want to go ahead and get your screen shared and we can go ahead and run through those slides real quick. I know we only got about 10 minutes, so we've got a few I'll work.I'll be fast. All right, there we go. All right. So yeah, first we got that quick disclaimer, we got to always do that. A story is not investment advisor and missing his spirit is in most gimmick where some losses of you who are new to store trading, what is associate is the practice of understanding market pricing.We also call that the story behind the trade through the four pillars, which we say are sentiment catalyst, fundamentals, and technicals. That allows us to take a holistic look at markets and make choices based on all of these factors, not just one of them. So air story, trade idea, update. I officially opened that in my community on July 8th of 2 74, I did close it on November 8th of 25, 79.I still own some shares. Uh, I ended up selling about nine giving 95% of my shares. Um, Monday morning was really the trigger for me and that's because I saw something, the technicals and also the sentiment, which caused me to say, let me, let me lock in these games. And the technicals last Friday was the.Solid green candle on the chart, you can go look it up the first solid green channel and then tire run-up, which, which means it started the day high and then went down lower throughout the day. And throughout this entire run, it was starting low and going higher throughout the day. I took that to be a reversal sign plus the sentiment, I think when reached peak Eby sentiment for now, for this cycle with, uh, Elon Musk selling shares of Tesla with the Caribbean IPO, with excitement, but Eby infrastructure.I'm trying to time that sentiment top. So I took my profits. I am keeping about 5% of my shares because it could go much higher still if they get the right contracts in the future. Got it. Um, so it took some money off the table, trim some of your position and air took those profits, never a bad move. Uh, Ben, what else?I was on your radar today. I wanted to give you an update on side, cause I was on your show. July 26, we presented this at $5 and 70 cents. Uh, this is stuff that's been up 66% since it was initiated in our community. At the time we said, Hey, T-Mobile's come in. End of month in August. It didn't happen then.But it happened last night. Uh, so a few updates. They have earnings last year. Um, so this T-Mobile deal came three months late, but it's finally here. Now, key, this was announced last night on the conference call only. There's no PR yet. So people who are in the know who are listening to the conference call, they have a big edge getting into the stock right now.Um, there probably will be a PR at some point in the future, and there's also tremendous traction with their other customers, 18 T and Verizon. Um, there was an upgrade today to $9 and I'm not even sure that Benzinga caught it, that upgrade by the analyst and $9 by lake street. But we think in our community, it can go much higher.Uh, there's uh, estimates out there in our community saying we can do go up to a dollar 33 DPS by 2024, which would be a $40 price target. So that's the update on SSI. You know, our investigative research worked and we're read about T-Mobile just a few months late. So this company is going to start printing lots of tests going to be a very profitable company.Do, do you have a target? Um, yeah, no, I don't have to stop losses. God forbid men. No, I do stories yet. I never do stop losses. So I've been holding the stock for like two or three years. I increase in decrease my position around catalysts. So, um, I was buying and after hours last night I bought a lot more today.It's now my largest position actually. And uh, I'm not going to put a price target. I see how it goes. I, I assess the fundamental sets of metallics and technicals on an ongoing basis to determine. There you have it. Yep. So I do have a new pig that I'll get to in a second. But before that, just a little quick alert, maybe something for you guys to look into and talk about, because this is a big kind of big cap for us.At $1.5 billion company GoPro. We presented it to our community Sunday night, um, because the fundamentals are super strong. They had earnings last Friday and we have anticipated a technical breakout of the 200 DMA, which just happened this morning. And this is really, it could be a really fun situation, wanted to bring your attention because it has, this has short and gamble, squeeze potential, very high, short position.He has sense of it has been very, very low, but the financials have completely turned around with this company and they're printing tons of cash. Now you see the technicals broke. The options are very liquid, very cheap. And if it gets into the right hands and the Reddit community, et cetera, this could be a crazy profit potential, you know, with shorten game of squeezes.So keep your eye on that. But go. So GoPro's up about 9% today on the strong earnings. Um, so I, I mean, I, I don't know, personally, Ben, if I'm going to go in and try to chase GoPro and it's already up 10%, but I, or 9% today, but I definitely like having it on my radar. Uh, J rice in the chat was also talking about GoPro saying that he thinks it could be a long-term turnaround play.Uh, I don't know. Munis has been one of those stocks that has just been like beaten down over time historically. Um, but you know, at some point I don't think you can ignore the fundamentals or Fridays when I got in added more Monday, uh, I got a little bit messed up on the options than playing the options.So I actually lost some money. Cause I got scared with the whole inflation thing yesterday, but I'm in it now and yeah, the sense of it's sport, that's the only thing people hate this company, but they're printing cash like crazy. The technicals are turning and shorting, given squeeze potential, such that this, yeah, my all hold back a GoPro has always been that.I feel like they have a very limited, uh, customer base, you know, it's like who, who who's going out and buying GoPros. It's people that take part in extreme sports, you know, mountain bikers, snowboarders, skiers, et cetera, outside of that. Um, I don't, I don't know how many, you know, everyday people are GoPro customers.It's absolutely correct. And I'm not, you know, I wouldn't take issue with that, but the amount of earnings they have like 60 million EBITDA this last quarter. And if you compare it with their market cap, I mean, this thing can easily be 17 bucks. Even with that knock against it. Got it. Um, I been, what else is on the radar?I have a presence. It's my first story. Trade ideas. Since air. I presented this to my VIP community last week. Okay. Listen to the presentation. Don't just jump into buying guys. Okay. Because of what happened with their, every stocks, not air, I can guarantee you, this is not going to go a thousand percent in the next three months, like heritage.Okay. So that sock is Gaia, ticker symbol, G a I a. All right. So we're going to look at it and yeah, it's a smaller company on the ground, 200 million market cap or so, but you know, what's the story behind the trade. That's what we're trying to figure out. And again, we look at the sentiment, the fundamentals, catalyst and technical.So let's start with the fundamentals guys, digital video subscription service, like in some ways like, like Netflix, they sell, um, they make original content for yoga, alternative health, holistic healing, nutrition. It's a monthly subscription service. They've been growing steadily over the last many quarters.They're profitable. Uh, fundamentally I think their inflection really happened to a quarter or two ago when they became profitable. And you can see some of the, uh, the trends here in terms of their, um, their revenue and their EPS, although in the right direction. So in our community, we collaborate with people who are really steeped in fundamentals, just charts, courtesy of Mark Holmes.He has a risk reward chart here in terms of what is the value of this stock and. You know, it's worth, it could be worth at least $17 a share. And the stock is very cheap here. So, so that's the fundamentals. You can check it out on your own. Go look at the earnings report and you'll be able to verify everything I'm saying about, uh, the growth and the subscriber growth and money they're making written it now.And it could potentially be, uh, you know, Netflix may buy them out one day. You know, there's, there's a lot of opportunities here. So, um, yeah, catalyst let's go to the next pillar. Uh, in these sorts trading four pillars, they had their earnings just recently, November 1st, it was 20, 20, 20 2% revenue growth, uh, year to date compared to last year Q3 EBITDA of $4 million.Uh, even a margin of 20% was their fifth straight quarter positive earnings in cashflow. Um, and then they had an additional catalyst the next day. So we'll talk about that catalyst in just a second. What happened the day after earnings, but first let's go to sentiment. So the sentiment is kind of poor with the stock because fundamental investors are frustrated at the price action.I know a lot of fundamental investors saying this should be worth 17, 20, 25 bucks. Why is it $10? Why is it moving yet? So I listened to other participants. I say, I talked to people in social media. I talked to people in my community. Why aren't you interested in the stock? And this is what I'm hearing.The total adjustable market may be too small. It may be too niche, their content. We talked about alternative medicine, yoga, meditation, and things like that. So it feels like I'm just not interested. It doesn't seem like a huge part. Other people say, Hey, the content, they have some content that's kind of fringe on their French content.Like some of that alternative medicine, there might be some videos on, you know, some vaccine hesitancy type stuff or who knows, like some things are it's alternative content, right? So some ESG, uh, buyers, uh, may stay away from that environmental social governance. So that's another knock on the sentiment.The other knock is this is just slow and steady growth it's and where's the hockey stick potential on that. So just remember, this is the poor sentiment. This is what happened. Going back to the catalyst the next day after earnings, after we know the fundamentals are great, the next day another catalyst hit the other, the catalyst was there was a PR that Demi Lovato became a brand ambassador for.And there was a press release that a lot of people didn't see a where Demi Lovato says I'm excited to be one of Dias. First celebrity ambassadors, and honor to join a platform. I've been a fan of for some time she has 118 million followers on Instagram. And the market cap is again like 189 million. So this company has been growing slow and steady.And all of a sudden, they hit you with this news of Demi Lovato is a huge mainstream personality, that and company, I want to go back to this. Airpoints the one thing I saw that the thing about Demi Lovato, uh, in, and I, I guess I didn't realize this was the same company, but like they got a lot of weird shit on their platform.And that was the sentiment I was talking to. They're saying, oh, there's stuff is weird. I just don't want to own this company. But you know, I think that, you know, they're growing steadily, they're getting to a place where they can really focus on growth now, and to me, and let me go back to that bad point.You just made that pinpoint. You brought it up for me, right? Yeah. They have weird stuff. It's too niche. The French content. They keep some buyers away. But this is where I think that Demi Lovato news is really significant because they're in a financial position now to really grow the company. And to me, this signals.And in fact, in that PR said, I'm excited to be one of guys. First celebrity ambassador, And I have a feeling this company is going to start growing their content and start getting into more mainstream content. And based on what you're saying, I think they may be looking for more celebrity ambassadors.And it's just a great situation because the downside is so limited. You have a fundamental floor here and now you have optionality upside. If the company starts doing things to get that hockey stick growth potential. And that's why I really add it to my position here. And I'm very excited for the next several months on this stuff.Um, let me just go to the last or technical resulted with her awesome technician Rex. And this is a monthly chart is saying, uh, this can go to the twelves if it breaks out of the yellow.here, which thought is that shorter than I think the current breakout circled right there. It's got a breakout of, I guess, 10 70 area.He thinks it can go to 12 for the month. And here's another view which looks much more bullish. This is a long view of the monthly chart is a sometime in the future. When the 12 to 13 breakout at the blue line, it should proceed to break out the all-time trend at the white line. And he thinks this is a several month play for that to happen, but you can kind of see where this can go.Uh, if that happens. Uh, any questions on that or any of the other stops, man? I didn't see this one coming. I didn't realize this. I read about this company and I was like, man, I didn't even realize they were a public company until you came on here. So, um, I'm all I'm putting two and two together here. Uh, Ben, thank you as always for coming on the show, we appreciate it and uh, and have a good rest of your day.Please follow us on YouTube. Thank you guys. Thanks a lot, Dan. We got to get moving. We got our next guest. She's already here. We're going to talk biotech guys. I know that we, we always get asked. We always get questions like when's Vivian. When's Vivian. When well she's on right now. Not right now. She'll be on in like five seconds when we bring her on.But Vivi Bio-Queen will be joining us every Thursday. At this time, I told you all to save your questions for your bites. The questions for right now, let's bring her on Vivi. How are we doing today? Good. How are you guys? Can you hear me? Well, we hear you. We see you and we have questions. Oh, awesome. And before we do any questions, I think, um, we can do some updates.I did have a request on Twitter to cover it stock. Um, like at my old good lawyer friend, mellow at Twitter, I, this is out for entertainment purposes. So, uh, is only my opinions are for entertainment, purpose, not a financial advice. So I wanted to, uh, first of all, um, talk to you guys, um, just given up a date, we just had the, uh, ER, on KMP.H can you guys put that up over there? Yeah, this is a daily chart. Okay. And P Hit's quiet. So, yeah, so we just had the ER and I want to, so when I, when everybody kept asking me, like, what do you, what are you going to do for 'em? What are you going to do for K MPH? My position was this small because he is a, some of the concerns I had. I spoke to the manager and he interviewed me. And, uh, he said, you know, we're not going to put any reps in New York yet.And it's just going to be certain regions in the United States. And for me, it showed a little bit of a weakness because for me, if you launching a drug, you should have put reps all over the map. But I think they're just trying to be cautious. So they report around like, I think 2 million in revenue, but here's what I'm bullish.Now. They just launched the rest of the Salesforce. And this company here, you know, their burn rate is really, really small because Korean is doing all the selling. So the burn rates is like a million a quarter and they have a, still have 135 million. And he is what I'm bullish of. Um, there's a company that sells a scripts and there's a guy that, uh, his friend works for this company and feeds him all the script.So for you guys to have an idea, right, the, the feedback has been amazing. So July, they had a nine scripts for the monthly and then August, they had 173 scripts, um, September 416, October 886, still low because there were not out throughout the nation. But I think the feedback has been tremendous from psychiatrist, from the drug and the differentiator.And I feel like as they deploy, uh, the other sales reps, we going to just ramp up the sales. So I feel like at this moment, I wanted to add a little bit more to my position because I, I see the future being very bright here, KMBH. And I think that, um, we gotnot yet. Not yet. I, I should have now I have an, I am waiting for some of my swings to flourish, so I haven't been able to, to add, but I wanted to for sure. Okay. And then I want it to put you guys out. Somebody asking me to, uh, to, uh, cover a, uh, a N N S. Hmm. Okay. Now I want I'm familiar with, but it is biotech.So it's a biotech it's under the radar. So I wanted to explain to you guys some of the reasons how I invest in biotech, and I told you guys, if there's no commercial products, there's, there's got the most important thing you can look at is cash, right? Because if you don't have a cash, no product, are they going to burn too much?And they also gonna have a, to do offerings. And if the stock is low, they do reverse the split. So the first thing I do is to look what was the cash burn and how much cash they have left in a would the future and what the catalysts are going to be. So this company here, the first thing that got me to, to look at it was they have a $271 million in cash.So they're really the city really strong. So I thought that was a really, really, uh, um, uh, valid, uh, information, very important. Then I look at a financial institution on. EVestment, which is a goblin, was the director of FDA is a partner on their firm. So they own 2.5 million shares. So I thought that was another very important information because goblet is well connected to FDA.Not that you know, it nobody's going to be bought out, but when you have investors that work with FDA, they know what it takes to, to be compliant, to get a drug approved, right. Because it's just so much behind to get a drug approved. So manufacturing, you know, how the studies are designed. So I like the fact that there's Nia investment behind.And then I also know VOD is, oh, 2.1 million. So Novartis has some interested and, and the pipeline, it looks really, really amazing is all CNS, um, uh, and mass. Um, they're going to have, uh, Gilliam Barre syndrome, which is a very rare disease. So I really like this company. I really do. I, I'm not, uh, obviously I can't be in every single stock.Uh, but I, I, I, I think this is a really good a long-term, uh, stock to hold for sure. So that would be one. And then if you can, um, bring back, uh, pro GPRO G we have a lot of fans PRG. It's like almost like a min stock, but also a really good stock to hold long and, um, really. Yes. Yes. So, so what, what do you see that the market doesn't see, um, what I see that the market doesn't see.Um, I will tell you why this company is going to be huge. They have a two types of, of delivery system. They have a, um, on, I'll tell you guys, they have a two to two technologies and I wanted to bring to you guys, let me see. I can share a screen. Okay. But I have it here right in front of me. So they have two things.They have the OBDs okay. Which is oral Biotherapeutics delivery system. So what it does is, is able to take big formulations and put in a form of a pill. So for example, Humira is one of the biggest blockbuster drugs in the world. If they found a $10 billion. So you imagine if Abby, I think Abby is a Humira honor.If, imagine if Humira is loses patterns and five years, right. And all of a sudden, because doctors love the efficacy of this drug, and that's why it's so well prescribed. Right? But it's an injection. Imagine for this company sell their technology. And all of a sudden you can have a drug, like a Humira being, um, given orally, all of a sudden you create a whole new patent for that drug.Do you follow me? Because a different formulation. So all of a sudden you gaining another 15, 20 years. I have a patent on that drug. Now imagine how many pharmaceutical companies would have be jumping all over because they like, geez, I have this, this drug that's high formulation. And now I have a, I would love this drug to be an oral form because patients do prefer to be an oral form.So I see, um, they announced that they have three partnerships with the big pharma, but they have announced who, so everyone is kind of on a suspense, like who are going to be the big pharma. So they have, uh, right now with the Pfizer there, just to have an idea, they, the not only the delivery, the delivery system does this to the big formulation, but also one of the drugs of four in any boat to the second one, the oral bio biotherapeutic delivery system.The OBDs, what it does is it's designed it to, to, um, to take it a pill and the pill, the way this delivers it, doesn't go all over your bloodstream. So it's it's for the GI tract. So is GI specific drugs and there's one. For for, for, uh, uh, Pfizer they're there. The preclinical, what they found was not only that, that would their delivery system, that drug was 25 times more potent than the Pfizer drug, but had a no toxicity because it doesn't go to the bloodstream.Like the other drugs would go. So you have a less toxicity, less, less side effects. So imagine what they can do if they already doing this with Pfizer drug, they're studying the Humira. Imagine like for me, this drug should have just literally like get royalties for every farmer, choose the technology instead of it being bought out.Right? So I believe this, the future of this company is super, super bright. Uh, you know, it's heavily shorted. So I think that a lot of people are here for the, the, the, the gum is squeezed because if you look at the amount of, of, uh, of, uh, options, that the options chain is crazy, uh, for this, for this company.But I, I will, like, I have a big position because I wanted to, you know, to trade around my core, but it's some, it's a company that I wanted to keep it. And, um, and a long term, uh, option, because I feel this company is going to be huge. So they just appointed also geo hall, believe it or not do, how do you, how, um, she's in a board of directors and this woman, it's like a powerhouse in biotech, a friend of my work.As so maximum, so messenger gas sold. So she comes in with a lot of experience in pharma and a lot experience in acquisition. So, uh, the team is fabulous. They are four miles away from my house. I should have just bring them a bottle of champagne when we hit $10. But I believe in this company, this company has a bright future and that, um, right now there's a lot of people on it, you know, waiting for that short squeeze.But, uh, it's been keeping really it's being holding like it dipped to, to like 2, 3 0 3 today and it went right back up. So it's been keeping, you know, I think the short sellers were expecting after der cause you know, there's, you know, a yard for a state, uh, initial stages of biotech doesn't produce revenues.Right? So it, it dipped to fund 360 2 all the way to three, but it's been holding for weeks at that average. So people are not selling people believe in this company for sure. Uh, can I ask you, what do you, what do you get, do you have any favorites in the, in the gene therapy space? I do. I, um, I, uh, I, I'm a loan holder for ADP and they have the, uh, it's one of the car T therapies, but it's not the car T is the RTC, uh, ADP.And, uh, the reason I like this company is, uh, not only they have a partnership with Genentech, uh, the Genentech partnership is up to three. And, uh, they already have enough funny from Genentech cause they got, they gave them a prompt payment payment. They have funded into 2024. So I feel like this is a very safe play in regards to not having offerings and that they are sitting with 285 million in the bank and they do have, uh, some, um, some, uh, catalyst coming.And, uh, I, I believe this company will be a multibagger on day, you know? Uh, so it's one of those that you set and forget it, but I like the position of cash because it gives me the comfort that they're not going to be throwing in offerings after a big catalyst. You know, they, they have they're in a really strong position.And when you look at, uh, um, institutional ownership matrix, all 15 million shares of this company, baker brothers owned 18 million, the institutional ownership. It's so strong in this company. And obviously Jen at that has a huge, huge portion of the company and has their eyes on the company. So, uh, this, this is a big one for me.I got to ask you about, about BCR X here. That's the rule. Every week we got to talk about BCR ex of course, it's this year access to my unicorn. You guys, for sure. So, um, it's, it's funny. I held this space as on Twitter yesterday, and I was talking to a pharm D you know, I do respect, they have a lot more knowledge than me, you know, uh, in terms of a clinical.And he validates my position on the CRX and GRTs, which is great stone. And he says to me, you know, be CRX is, is a rare diseases monster in the making. So they, um, they just released the earnings. They put 38 million for the quarter, and people, BU people were really upset that it wasn't 7 million like this huge numbers, but for the mentally long-term, it's still there, right.Because the science hasn't changed. So I see this as an amazing opportunity, uh, if you're not in the CRX, but, uh, just, you guys have an idea. Uh, the biggest drug for, um, for Alex yawn is, uh, Alto Morris. And they are not even that good because it's not only an infusions for PNH, but patients still need transfusion, uh, taking this infusion every eight weeks.Uh, BCRA X has the competitor, which is going to be an oral oral, uh, competitor factor D and not only patients that have been on this study up to now, not only they jumped from phase one to phase three, because they did so. Patients to this date. I think there's 40 weeks, 30 weeks of, could it be this fusion to this date?So imagine having a drug that is, it's already a rare disease for PNH and patients only at the choice on the available is in Jackie, no infusions. And you still have to go through the transfusions. Imagine having an oral pill that you don't have to have a transfusion at all. So just make them do the math and Alex, the on 70% of its revenue, 70 was on PNH for this drug and they got bought out for $39 billion that would have put the CRX at a $230 a share.And B CRX has a better pipeline with a more potential and it's going to be all oral. So you guys do the math, if you don't think this is a monster in the making. Alright, Vivi the bio queen, she joins his every single Thursday at biotech. Underscore SD is for Twitter handle it's up on the screen. And uh, and then please.Yeah, please, if you, I will post my DD there because this is a very short, so you guys searched the bioclean on Twitter and you can find me all right. Thanks a lot. Viva, talk to you again next week, next week. All right. Uh, Hey, let's stick with biotech for a second here because our next guest is the CEO of a gene editor.Company, hence why I asked to VV about that one to get her thoughts. So, uh, if we can, let's go ahead and, uh, and, and, uh, bring her on guys. Andy Ford. She's the president CEO of Mira GTX. His company is a lot going on right now. They're at a very critical point. So let's get Zandy onum, Ford,by the way. Yes. Thank you. Thank you. Where we're actually, it's on our to-do list to get new music, but, um, thank you for, for, for the compliment. Uh, so as I said, it's a pretty critical time for, for mirror DGX. Uh, you guys just presented at, uh, uh, the virtual, uh, oh gosh, uh, the European society of gene and cell therapy Congress, right?Uh, yes, we did add three abstracts. Yes. Right. And then there's a, we're due for another, a little bit surprised when I found out you're on the calendar. Cause I thought you guys, you have another, uh, presentation coming up in a few weeks. I, I, I think I believe right. We do. So we have, um, quite a number of presentations in the second half of this year, uh, which included, uh, some presentations at the meeting.You just mentioned on our programs and our switch that allows you to switch gene therapies on and off with a pale. Um, related to what video was just talking about, actually, that's what I do want to talk about. I'm sorry about, and then, uh, at the beginning of December, we, uh, having a clinical update on our xerostomia program for patients who've been cured of had a neck cancer, but don't make saliva.So we'll be completing that study this year and we'll be updating on the clinical progress so far at the beginning of December. And then a couple of weeks later in mid December, we're having a science day to discuss in some more detail, uh, Ribas switch technology and our promoter platforms, which allow us to really optimize gene therapy.And for the first time switched gene therapies on and off with an oral drug and not just switched them on and off, but quite precisely dose the amount of gene therapy at a particular time with a dose of an oral pill. So let's talk about the switching via via pill. Yes, exactly how that. So obviously gene therapies are a virus which contain a gene and there's a coding sequence of the gene, which will make your protein, whether it's Epogen for example, or whatever, uh, gene therapy, it might be RPG or for the eye.And that gene is activated by a promoter, a regulatory sequence at the beginning of the gene. So that's the normal gene therapy promoter and a gene, the promoter switches the gene on, and it remains on for the rest of that patient's life, all that sells life. So you have persistently expressed gene therapy, but what we've been able to do for the first time is we do everything.I've just told you with the promoter that regulates the gene therapy and switches it on. But on top of that, we put into the gene sequence, a small sequence of DNA, which instructs the entire RNA produced from that gene to degrade. However, if we give a small molecule, but via pill, and we've got many small molecules, because we've developed this as a platform, it stops that degradation.It cuts the entire degrading sequence out of the gene. Produced RNA and you'd get the gene switched on as if it was never there. So for the first time we can deliver gene therapies, which are not on, so they're not producing weird proteins or bits of proteins. And we give a pill and bomb that I'll call it.The degrading signal is cut out of the RNA and you get a perfectly normal protein product.I guess I have so many questions. I don't even know where to, I like that all sounds incredibly complicated. Um, I guess, uh, how can you make sure that it works? So it's, we've when we set up the company, this was one of the technologies that we, um, we wanted to build and these switches made of RNA shape.There are thousands of them and bacteria. And for, for decades, people have tried to take bacterial switches and make them work in human cells. And rather than doing that, which hasn't worked very well. We built, we use the theory of Reiber switches and we built based by base our own switch. So we built it in mammalian cells.We then tested many switches and we have a platform of switches we can control. We were able to make these really simple switches, which switched on and off to high dynamic range. So 5,000 fold above the off level when they're switched on. And as a consequence of that, we were then able to change the drug that we activated with.So now we have multiple genes that we've put our switches in sitting in our freezers. So, uh, various antibody, PCSK nine antibody. You'll be aware of, uh, PD, one antibody, the, the very large drugs we can regulate. And then other drugs like GLP one, obviously a diabetes and obesity drug, which we can regulate.So we've got those genes and we can now put them into vivo in mice and NH PS, and we give those animals small molecules and we've already shown. Based specifically on the dose of the small molecule, we see our drug switched on to exactly the right level in each animal, depending on the dose of the small molecule you give.So we have built this over the last five years and we have moved from cells to mice, to non-human primates. And we're currently in a position to start doing I N I N D enabling studies for both the small molecule, all drugs and the genes that they regulate. Uh, and then as far as use cases, I know you're working on, um, you know, you're working on applying this, um, to, uh, I disorders, right.Uh, but is that the only use case right now? Tell us about the other one. No. So, um, we developed this technology of controlling gene therapy with a pill in order to much more broadly open up the space that gene therapy could be used in. So. We do have a lot of expertise in the eye and a partnership with Johnson and Johnson for our rare eye disease programs, but in diseases like wet AMD or dry AMD or uveitis, those large diseases.These are targets for regulation with our cassette and small molecules. In the case of our wet AMD program, we inhibit VEGF like other companies do. But what we're able to do potentially is when we put that gene that blockades by Jeff into the eye, we can formulate one of our small molecules. That's otherwise oral into eyedrops.So what we're working on now is turning our small molecules into eyedrops. So we can put a wet AMD drug or uveitis drug into the eye as a gene and switch it on each day with an eyedrop. So the eye is an excellent place to be able to regulate gene therapy with a small molecule, another place, which is really important is in the brain because it's very difficult to get antibodies or biologics across the blood-brain barrier.But what we're able to do potentially is we have regulated antibodies and we can put the. By an injection into the brain, just a one-time injection within the blood brain barrier. And then all you need is a pill which crosses the blood brain barrier. So it allows us to deliver drugs that really hard to deliver by other routes.And there are many, many more applications. It, it hugely expands what you can use gene therapy for, because for the first time you can control how much you gave. And at what time, uh, it seems like broadly speaking Zandy, um, gene therapy, like what, like as an investment, it was like super sexy a couple of years ago.Right. And then it sort of, it was super hot and then came down a little bit and was like, oh, wait a minute. This is still really days. Where, where are we now? Are we like back to, is gene therapy being like the hot, the hottest topic in biotech? Or, or are we still sort of, is it like the off cycle? I dunno how else to phrase it?W well, I think there are, there are many different gene therapy companies and there is cell therapy companies. There are very, very large number of, of, uh, therapies in the genetic medicine space. And, um, and there are some companies that just have a product or a platform or a particular organ that they focus on and that.Is a somewhat higher risk to those companies that depend on data around a particular study, right? What is quite different about mirror is that we established the company to really innovate in gene therapy and shows indications in the clinic that had good proof of concept and highly likely to work and to support a future pipeline.We built everything you need to be a gene therapy company in-house so we have multiple promoter platforms, multiple capsid discovery efforts. We have our own internal manufacturing, which is probably the broadest engine therapy today in that we manufacture our own GMP plasmid. We have two, uh, viral vector manufacturing facilities, which are flexible and scalable to commercial scale.And we do our own QC and analytics as well as potency assays. So we have a very, very broad, I suppose, toolkit that's required for anything. That you need to do in gene therapy and went out, positioned with this regulation ability with a deep pipeline of regulated genes that we can then take through to the clinic with our vector ecology and our own GMP manufacturing,not of the regulatory by putting all that in house. I was just gonna ask, as, as we get more developed in this space, like Spencer said, it seems like a couple of years ago, you know, that the gene editing space was huge for investors. Uh, what advice would you give investors that are looking at different, uh, you know, genomics companies to, to be able to discern which ones are going to have an advantage in the, in the field once the industry does become more hot among investors?Again, I do think that right now, manufacturing is not just a bottleneck with respect to capacity, but, um, Dealing with regulatory agencies globally and an expertise in manufacturing process. And, uh, and the assets required to show the release and stability of your products is very, very important. And to be able to either have that, to have as much of that as possible in house dearest clinical programs that you'll see, particularly if you have those sorts of capabilities at the time of D you really don't want to see companies that are starting manufacturing their product in one way.And then at phase two, switched to another way and then have to scale it later. Ideally, you would look for companies that have capabilities that allow them not to necessarily rely on CRS for plasmid manufacturing or in DQC. And we learned that over the last five years, it's one of the reasons we've bought, uh, so many of these capabilities in house, but I do think that's very important.Um, in addition to obviously, you know, do the targets work or is this, is this an appropriate, um, disease for gene therapy, the nuts and bolts of being able to produce and show the agencies that you've produced the right thing, a really important. Zanni Forbes is the presidency of Mira GTX. As I mentioned, there's a lot going on.You guys also got some positive in Canberrans over the weekend and, uh, uh, a lot of presentations after being in stealth mode for quite some time. So, uh, looking forward to seeing how things develop here and, uh, and, and, and good luck going forward. Thanks a lot for coming on today. Thank you so much. All right.Hey, w we got to keep the train running on time here. We've got so many guests today, back to back to back to back let's pivot. If we can, maybe we just spent the last half hour or so talking biotech, uh, let's pivot to like supply chain, specifically, uh, supply chain of textiles, right fashion. And what exactly is going on there?What to find out? We're going to bring on our next guest here in just a second and running Samuel. He is the CEO of a cornea technology, and, uh, let's bring coordinates and a Ronan. W that's been running on this show. Now, if we can guys, I guess I'm Spencer, I guess I'm doing that. All right. I got you right.There you go. Good morning for us this afternoon for you it's later on in the evening. So I appreciate you, uh, coming on, uh, the, the, uh, the show here today. So, uh, let's talk about textile supply chains, right? Uh, what exactly is going on there right now are things as bad there as they are in other areas of the.Well, um, yeah, it's bad. And it has to change the supply chain is broken, but even more than that textile industry and fashion industry in particular is the second most polluted industry in the world. Um, from different reasons. One of the reason is that 30% of whatever put use on textile is actually never been sought.Uh, and this create a huge amount of waste, both of materials and water, and we have to save the world. Um, uh, so we have to change the industry. Now, the reason for that is some of it is because the supply chain of today doesn't meet or doesn't fit the need of the consumer of today. The supply chain of the textile industry is like centuries ago, you produce in large quantities in forest, in China, in Magilla dish, you trying to forecast what the consumer, what the people would like to buy a year in advance, sometimes 18 months in advance, which is impossible.It's crazy to think that you can predict what the consumer today would like to wear in a year and a half from now. So we have to change it. The world move to digital in many, many industries. And in this industry is still fully. Yeah, I'm glad you brought up the, uh, you know, the environmental impact of the textile industry, because that's something that's gained a lot of attention over the past year or so.I mean, you have a quote unquote fast fashion companies, such as sheen and people have kind of started attacking the, the idea that, oh, buying, you know, a cheap t-shirt for $15 or some pants for $15 that you see an ad for an Instagram, uh, causes a lot of environmental distress. So what do you think needs to be done in the industry to address that?So they, this would need to change in order to try to predict what the consumer would like to buy and put, use Lauder moms of products, which will never been sold is to produce, to demand, to produce after the consumer.But that's not efficient. I mean, it you're saying it is, but that's not a necessarily inefficient use of capital though, right? No, no. It's, it's actually a very, very efficient, um, hold on, explain to me, explain to me, yeah, let's begin with, first of all, what we see that production is really moving on shore.Why it's moving on shore, not only because the, the, the supply chain is broken because you have to be closer to the consumer. You have to react fast for the consumer trends. Now, the world of fashion and textile move is moving online today. 30% of all purchases being done online. So e-commerce the focus by 2025, that it will be more than 60%.Now, the online the e-commerce of today is still trying to sell you what they have in the inventory or what they have in the shops, in the stores. Uh, and if you going to order products, sometimes it does not exist at all. Um, and uh, sometimes, um, for the brands is really, really difficult to. Okay. Can you hear me okay?Yeah, we, we, you we're fine. We just got disconnected, but we're back. Okay. So, so I missed everything you just said. Okay. Okay. So let me try to explain again. So the world is moving digital. What does it mean? The consumer today's buying? So e-commerce online. 30% of all sales is being done online and the focus by 2025, that it will be 60%, but the online is today's actually a mirror of the store.Doesn't allow you to choose your product. They're trying to sell you what they have in inventory, which doesn't fit what this consumer would like, what we believe needs to be done, that the online should be filterable. You shouldn't have any real physical products. You can have endless amount of product virtually and connect the virtual wall to the physical world.And this is exactly what committee's doing is enabling on demand, production. You order what you want only. Then you produce it. You produce it close to the consumer. Onshore and delivering, you know, the same day on the next day to the consumer, the product, I feel like this is I'm in now. It sounds great. I think that, but that's like, that's more difficult, right?Well, I give it a few examples. Well, one example, great example. Thinking about the books book markets, um, back at 25 years ago was fully analog. You went to a bookshop, you tried to buy a book. You only have them, the shelf, the books that we're selling in millions of copies, Amazon disrupt this market. They created a digital world.You could go to Amazon buy any type of book, even from 200 years ago. But what they create is actually much more, the impact was much more than that because now everybody can become a writer. You can write a book about your family, about cooking, about anything you like, you publish it. Virtually doesn't cost you anything.Only when someone is ordering, then you print it and send it to the consumer. So the same thing is happening now in the fashion world, you don't need to have it physically. You actually unleashing creativity because you can have endless creativity and each one of the consumer can choose whatever they want in any Colleen, any design.And once you choose it only, then you produce. So this is efficient and there is no way. And you produce it using coordinate technology, which is a fully sustainable green technology. That was my next question was just if you to clarify that, so I come up here like Amazon, for example, uh, could have used your technology, right.Or, or any retailer, right? Could just buy your technology and, and use that along their supply chain to make it more and more green, more efficient. Right? Actually, Amazon is our biggest customers. Okay. Amazon is our biggest customer, but we have many, many more customer. We are worth more than 1000, 300 customers that using our technology all over the world.Some of them very big companies like Amazon, like Adidas, like fanatics, but using our technology. And you can go online and order products and customize the product and order your t-shirt here. You can see with coordinate on top of that or on any color, any size, any shape. And this is the new world. Look what the world is moving into.What is moving into metaverse. So metaverse is everything is virtual. You will have. Your image in the metaverse. Yeah. You will be able to dress it as you wish with any, any type of, of, of goods. Uh, and only when you feel that you lack it, then you order it and then it would connect it to the physical world, which will be big produce next to you.If you are in New York, it will produce in New York. If you are in Beijing, will be produced in Virgin and shipped to you the same day. So the impact on the environment in terms of sustainability is huge and their efficiencies and believable, and the creativity is unleashing the creativity for the designers and for the brands.W why is no one else doing this? Or are they well, uh, there are some, uh, companies, our customers that using our technologies like Amazon are doing it. If you go to Amazon and you're doing what you're doing, right. That's what I meant because, well, we are kind of unique festival in terms of the physical world.We out technology, what we have developed is systems Inc services that is all sustainable, which are digital systems that can produce one off. If you want it to produce a t-shirt or any, any government or any fabric in the, in, in the past using analog technology, you had to print where to produce hundreds of meters in order that it will be economical and.The sustainability impact is huge. Um, there's a lot of pollution and consumption of water for every meter without technology, because it's digital, you are not limited. You can print one t-shirt, you can print one meter, one fit, there's no limitation and every feed can be different design. So this is the advantage of digital is unleashing the limitations that you had before, and we are not using water.So there's no, there's no water consumption. It's pigment ink. So it's fully green. So no impact on the environment. So like who couldn't use corny Amazon obviously, but they're the largest retailer in the world could, could, could I use it on my online Shopify store that make, that sells? I dunno, 10 shirts a year.Exactly the point it's off form. The biggest retailers, biggest e-commerce biggest brands like Adidas, Nike. They of course can use it to anyone, any consumer that would like to open a shop in Shopify. Now, what is the problem with Shopify? If you are now at this time? And you see somewhere in India and you would like to, to sell your product.You open the shop in Shopify in five minutes, you put your design, what is the problem? Once you get the order, what are you going to do with it? How are you going to produce it? Are you going to ship it out? We can compete against other marketplaces. What call Nita Naples is to connect all those and marketplaces all those designers in to a network of fulfiller that can fulfill for them.So you need to take care of only on the design, open a shop, and then connected to Coney ticks. And kinetics is a platform that connect them to a network or fulfiller that using our technology and can produce it anywhere around the world. And it sounds good. The market clearly likes it. Cause if you, if you look at your stock, it's had a pretty tremendous run actually, even, even last year, uh, seemed to, uh, COVID, didn't seem to hold it down too long.So, uh, the market agrees with you. Uh, so I, I guess keep doing what you're doing. Uh, running Samuel was the CEO of, uh, coordinate, uh, digital. Uh, we will have to get you back on the show. Uh, hopefully, uh, now maybe next year when, when the supply chain starts to work itself out a little bit, but I, I I'm, I'm very curious about this space because, uh, you're, you're one of the best performing stocks, uh, I think out there probably right now.So, uh, Ronan, thank you so much for coming on the show today. Thank you very much. Pleasure being here. All right. Uh, it is, uh, 1259. We've got our next guest coming on in couple minutes. Whenever minute when it, whenever they join, to be honest, cause they're not even here yet, but that's okay. Uh, Scott Mathis is the CEO and chairman of Gacha holdings, ticker V I N L a.And then we have, I'm very excited for our one to 30 guests, but we're not a Capels from Benzinga and, uh, really Benzinga is, is a side it's his side gig. His main gig is, uh, is doing really complex. Trading stuff, strategies. So, uh, I'm, I'm very, I'm very much looking forward to that, uh, in a half hour. Uh, if we can think of who executive though, and I have not grabbed, voted for likes yet this hour as we enter our two of our show keyword yet, uh, if you could be so kind and hit that thumbs up button on your screen, I'm not sure where we're at on the light counter right now.Let's look, we're at the de come on computer 74, 75. We can do better than that. We do over a hundred easy, easy. The goal for the goal for the day is 200, but we can get you a hundred right now. I suspect. Yeah. So before we get to Scott Mathis with a wild show holdings, um, the, uh, the previous guest, I liked that idea of cause basically what he's saying is that companies now are producing clothes for a year down the line, right?But they don't know what's going to be hot on Instagram and Tik TOK and what the trends are going to be efficient. It's not efficient. So what, what he's saying they're doing is waiting and basically it's print on demand, but on a huge scale, like what Shelly was talking about in the chat with the economies of scale, they're able to produce, uh, the goods for cheaper when they're doing it on a large scale.If everyone, if they're, if their technology is able to kind of shift that whole industry, it would have a tremendous impact on, uh, the environmental right now, the negative environmental impact that the textile industry has. Another fun fact. Spencer, did you know this, that a lot of luxury brands, um, such as, you know, Gucci, Louis Vuitton, do you know what they do with their extra extra goods?No, I don't want to say something that's politically incorrect, but I know I have no idea. What could, what would the, I don't know. They, they, they, they give it the, give it to animals. I don&
Laurence Marshbaum is Chairman and Founder of 10x10 Philanthropy, an organisation dedicated to engaging young people in philanthropy all around the world and to help those most in need. Laurence would come up with the 10x10 model after his friends began to express that they were bored with going to gala dinner after gala dinner. Since then, 10x10 has spread around the globe to 13 different cities and has raised $3.8 million.Get all the links mentioned in the episode here: SKIP THROUGH THE EPISODE:00:24 - Guest intro00:39 - Laurence's nickname03:58 - Earliest childhood memory & lacto-chat05:59 - Laurence's parents & AUS Vs UK07:53 - Parents' professions10:13 - Why finance?14:01 - Laurance's journey to philanthropy16:40 - The why behind 10x1021:02 - 10x10's model: no more galas?25:49 - The 10x10: sustainability & the future31:09 - What makes a charity successful & effective37:28 - What is effective altruism & it's effects on 10x10's work48:41 - Balancing the grind50:49 - Books on philanthropy53:56 - 10x10 committees plug
Chairman of the Joint Chiefs of Staff, General Mark Milley says his opinion on the Afghanistan withdrawal was to leave 2,500 to 3,500 troops on the ground to facilitate a peaceful removal of American citizens and allies. This directly contradicts President Biden's contention to George Stephanopoulos that no senior military adviser gave him that assessment. Further, CENTCOM commander General Kenneth McKenzie seconded this opinion, and Secretary of Defense Lloyd Austin echoed those sentiments as well. So who was in the room telling Biden that cutting and running was a good strategy? Is Biden simply going senile, or simply the worst person to occupy the Oval Office?
This experimental round table discussion features Connor O'Hanlon + Evan Transue. Together with Colin, they explore the complexities of America and life as we know it as American citizens. Follow Connor O'Hanlon via His progressive podcast @theconohshow on IG Strength Coaching @asgardiastrength on IG and he is the Chariman of the Doylestown Democrats. Follow Evan Transue via @evan_transue on IG http://evantransue.com and The Health Coach Ev Show on Apple Podcasts, Spotify or WWDB-AM ------------------------------------ Special thanks to our sponsors:::: Philadelphia Table Company IG: @Philadelphiatablecompany phiadelphiatablecompany.com And to Native Cafe in Doylestown IG: @nativecafedoylestown 12 South Main Street Doylestown PA 18901
Today we discuss the 2021 awards season darling, Judas and the Black Messiah. Starring Daniel Kaluuya, LaKeith Stanfield, Jesse Plemmons & Dominique Fishback. This film is about the tragic life of Fred Hampton, Chariman of the Illinois Chapter of the Black Panther party.
In Season 2, Episode 9, Simon talks to Sach Kukadia. Sach is a serial entrepreneur, non-executive director, chairman, board advisor and angel investor. He launched his first start up, SecretSales.com at the age of 22 and over a period of 10 years, raised £18m through leading Venture Capital Institutions and drove annual sales of £47m. He eventually sold the business to a London based Private Equity firm in 2017. Sach's current interest lies with Residently, a disruptive Property Tech platform alongside a new D2C business launching in Q2 2022 that allows you to invest in gold. In addition, Sach is Chairman to vintage furniture business Rehaus, and NED to a number of other consumer facing businesses.
In Season 2, Episode 9, Simon talks to Sach Kukadia. Sach is a serial entrepreneur, non-executive director, chairman, board advisor and angel investor. He launched his first start up, SecretSales.com at the age of 22 and over a period of 10 years, raised £18m through leading Venture Capital Institutions and drove annual sales of £47m. He eventually sold the business to a London based Private Equity firm in 2017. Sach's current interest lies with Residently, a disruptive Property Tech platform alongside a new D2C business launching in Q2 2022 that allows you to invest in gold. In addition, Sach is Chairman to vintage furniture business Rehaus, and NED to a number of other consumer facing businesses.
In Season 2, Episode 9, Simon talks to Sach Kukadia. Sach is a serial entrepreneur, non-executive director, chairman, board advisor and angel investor. He launched his first start up, SecretSales.com at the age of 22 and over a period of 10 years, raised £18m through leading Venture Capital Institutions and drove annual sales of £47m. He eventually sold the business to a London based Private Equity firm in 2017. Sach's current interest lies with Residently, a disruptive Property Tech platform alongside a new D2C business launching in Q2 2022 that allows you to invest in gold. In addition, Sach is Chairman to vintage furniture business Rehaus, and NED to a number of other consumer facing businesses.
New York GOP Chariman Nick Langworthy LIVE on LI in the AM w/ Jay Olvier! 2.25.21 by JVC Broadcasting
"If your actions inspire others to dream more, learn more, do more and become more, you are a leader." Listen on to up your skills & learn from the very best in the business world .
The Equal Employment Opportunity Commission is undergoing a change in leadership and makeup as the Biden administration takes over. Now we check in the former chairman, and a commission through 2022, Janet Dhillon.
Caught Listening continues it's "In Memoriam" series by remembering the life and legacy of two legends of the game who passed away in 2020. Don Larsen and Whitey Ford are synonamous with the New York Yankees franchise but their lives and statsheets could not be more different. Helping us remember these two giants of baseball, and the differences between them, is longtime New York Times sports columnist George Vescey. From how Larsen's perfect game in the World Series defined his career, to his military career before making the Majors, George helps expand on the life and career of Larsen. As a man who covered Ford during his career in Pinstripes, Vescey reminisces on the man known as "The Chariman of the Board" and his impact on one of the most recognizable sports franchises in the world.Vescey also answers the question of who now holds the title of "Greatest Living Yankee" after the passing of Ford. Be sure to search "Caught Listening by Public House Media" on Twitter, Facebook, and Instagram to be a part of our next episode. You can also email the show at CaughtListeningPHM@gmail.com
Space technology – innovation made in Hungary. This was title of the online roundtable discussion organized by the Industry and Entrepreneurship, Development Economics and Startup Sections of the Hungarian Economic Association (HEA) held on Thursday, November 26, 2020. The keynote presentation of the English-language event was given by Péter Hargitai, Chariman of the Hungarian Space Cluster. In addition to him, the participants of the subsequent professional panel discussion were the leaders of three Hungarian space industry startups: István Arnócz (Space Apps Kft.); Bertalan Eged (Sagax Communications Kft.); and Károly Kornél Schlosser (Goldsmiths, University of London; Aquanauta Center for Exploration). The moderator of the discussion was Miklós Kozma, associate professor of the Corvinus University of Budapest, chairman of the Industry and Entrepreneurship Section of HEA.
Suffolk GOP Chariman Jessie Garcia LIVE on LI in the AM w/ Jay Oliver! 10.22.20 by JVC Broadcasting
Support the Show I interviewed Enrique Tarrio the chairman of the Proud Boys to find out what he thought President Trump meant by "Stand Back and Stand By", I confronted him directly on the question of White Supremacy in the group and why the SPLC named them a hate group.
Gordon Chang, columnist, pundit, author and China expertTopic: China's military buildupFrank Siller, Chariman and CEO of the Stephen Siller Tunnel to Towers FoundationTopic: Upcoming events honoring the victims of the 9/11 terrorist attacksClint Lorance, former Army Infantry Officer and Paratrooper sent to Fort Leavenworth military prison in 2013 & pardoned by President Donald TrumpTopic: his new book, "Stolen Honor"See omnystudio.com/listener for privacy information.
The ninth episode in the COVID-19 series features a conversation with John Green – Chairman and CEO of Revolution Farms, Chairman of Cirkul and Odyssey, and former Executive Chairman of Founders Brewing. John speaks to managing cash, how this crisis is impacting indoor agriculture, and how he leads multiple companies through this crisis.
Upfront May 05 2020 Guest Woonsocket City Council Chairman Daniel Gendron
In this episode we managed to get the insights to the pressures of running a football club from Toby Macormack, the Chariman and CEO of Warrington Town FC. A club that are currently playing in the Bet Victor Northern Premier League, which is the 7th Tier in English Football. We find out how the team prepared for that famous FC Cup night here in Warrington, how we can become more invovled with the club as they push for promotion and the impact the club has on the community and it's supporters. Thanks for listening!
EN: Tim Höttges, CEO of Telekom speaks to Ola Källenius, Chariman of the Board of Management of Daimler AG and Mercedes-Benz AG about Inspiration, customer centricity and the development of technologies in the telco industrie as well as in mobility. DE: Tim Höttges, Vorstandsvorsitzender der Telekom spricht mit Ola Källenius, Vorsitzender des Vorstands der Daimler AG und Mercedes-Benz AG über Inspiration, Kundenfokus und die Entwicklung von Technologien sowohl für die Telko Branche als auch für die Auto Industrie.
Dr. Gregory S. Johnson and Dr. Vicky Johnson come onto the HET Podcast to share their perspective on managing and operating a continuing education company. They also touch base on some of the main topics and issues regarding physical therapy continuing education and SO MUCH MORE. Resources Mentioned: Institute of Physical Art APTA Combined Sections Meeting World Confederation for Physical Therapy Congress 2021 International Federation of Orthopaedic Manipulative Physical Therapy (IFOMPT) Conference 2020 Functional Manual Therapy Foundation The Saliba Postural Classification System Maitland Approach Biographies: Gregory S. Johnson, PT, FFFMT, FAAOMPT Co-Founder Functional Manual Therapy® Co-Founder/Co-Director Institute of Physical Art Co-Owner Johnson and Johnson Physical Therapy, Steamboat Springs, CO Partner/Owner IPA Manhattan, A FMT® Physical Therapy Services Clinic Partner: Vardan Functional Manual Therapy® Services, New Delhi, India Board Member, Functional Manual Therapy® Foundation Senior Faculty, APTA Credentialed Orthopedic Residency Program Director, APTA Credentialed AAOMPT Functional Manual Therapy® Fellowship Program Honorary Fellow: AAOMPT: November 2012 Gregory S. Johnson, PT, FFFMT, FAAOMPT, graduated from the University of Southern California in 1971 and completed a one year residency program at Kaiser Vallejo under Maggie Knott. He remained as senior faculty for six years. Mr. Johnson is best known for his identification of the need for Physical Therapists to integrate treatment of the facial system into manual therapy and the development of the first Soft Tissue Mobilization course for Physical Therapists in 1980. In addition, Mr. Johnson utilized his extensive background in PNF to adapt standard manual therapy techniques of Joint Mobilization and develop the dynamic techniques of Functional Mobilization™ and Resistance Enhanced Manipulation™ (REM) techniques for joints, soft tissues, and neurovascular restrictions. Mr. Johnson has trainied or directed the training of over 40,000 therapists in the USA and internationally. Gregory Johnson is the co-founder and President of the Institute of Physical Art, the co-developer of the Functional Manual Therapy® approach to patient care, and the Director of an APTA credentialed AAOMPT Fellowship program in Functional Manual Therapy®. He has published multiple chapters and articles on Soft Tissue Mobilization, PNF and the Orthopedic Patient, Functional Mobilization™, and Functional Test for the Lumbar Patient and is currently involved in several research projects on Functional Manual Therapy®. Vicky Saliba Johnson, PT, FFFMT, FAAOMPT Co-Founder Functional Manual Therapy® Co-Founder/Co-Director Institute of Physical Art Co-Owner Johnson and Johnson Physical Therapy, Steamboat Springs, CO Partner/Owner IPA Manhattan, A FMT® Physical Therapy Services Clinic Partner: Vardan Functional Manual Therapy® Services, New Delhi, India Chairman of the Board, Functional Manual Therapy® Foundation Director, APTA Credentialed Orthopedic Residency Program Administrator, APTA Credentialed AAOMPT Functional Manual Therapy® Fellowship Program Honorary Fellow: AAOMPT: November 2012. Vicky Saliba Johnson, PT, FFFMT, FAAOMPT has 34 years experience as an educator and clinician in the area of neuromuscular facilitation and motor control training. Her post professional training includes studies with Paris, Grimsby, Maitland, McKenzie, Johnson, Rocobado, Wetzler, Hodges, and the six month intensive in PNF at Kaiser, Vallejo under Maggie Knott. As co-founder of The Institute of Physical Art and co-developer of the Functional Manual Therapy® approach to patient care, Vicky Saliba Johnson has facilitated the training of over 40,000 physical therapists in the US and internationally in the area motor control and neuromuscular facilitation for both orthopedic and neurologic patient care. In addition she has provided corporate training for preventative care at large companies such as PG&E and 20 Mile Coal Mine (at the time the largest underground mine in the world). Ms. Johnson is Chariman of the Functional Manual Therapy® Foundation (a non-profit 501 (c) 3 foundation whose mission is to promote research in manual therapy), Director of the APTA credentialed IPA/FMT Foundation Orthopedic Residency, senior faculty for the APTA credentialed AAOMPT FMT Fellowship program, and adjunct faculty at Touro College of Physical Therapy. Her primary professional contribution to Physical Therapy is her work as the developer of the CoreFirst® Strategies approach to posture and movement training which facilitates an automatic core response during functional activities for life, work, and recreational activites. She has co-authored several chapters in various Physical Therapy textbooks and has presented at multiple state and national conferences, including IFOMPT in 1994 and the World Conference for Physical Therapy in Amsterdam June of 2011. She is currently involved in state of the art research exploring the correlation between alignment and functional strength. Contact information: Website: instituteofphysicalart.com Facebook: @instituteofphysicalart Linkedin: Institute of Physical Art The PT Hustle Website Schedule an Appointment with Kyle Rice HET LITE Tool Anywhere Healthcare (code: HET)
Steve Adubato and Mary Gamba are joined by Kevin Cummings, Chariman of the Board & CEO, Investors Bank, to discuss leadership and communication skills.
Getting two unbelievable leaders to join the show at the same time leads to incredible conversation. That's what we have this episode, as Ruel Joyner and Michael Owens discuss reluctant leadership, stoicism, growing a family owned small business, handling 14 million visitors to the city of Savannah GA, and much more. Ruel is the owner of 24e Design as well as Commissioner of the Georgians First Commission. Michael is the President/CEO of the Tourism Leadership Council as well as the Chariman of the Georgia Travel Association. We get past surface level conversation and go deep throughout the entire show. You can reach out to Ruel at Ruel@24estyle.com, or visit the company's site at www.24estyle.com. Feel free to talk with Michael at Michael@TourismLeadershipCouncil.com, or visit www.tourismleadershipcouncil.com and www.georgiatravelassociation.com. If you have questions for me or know somebody who should be a guest on the show, email me at Ben@SkywardVenture.com. You can check out other episodes and clips of the shows at www.SkywardVenture.com.
Jake is the founder, Chariman and CEO of Praetorian Global. In 2015, Jake capitalized on his unique experience of building luxury brands by founding Praetorian Global and creating both the Binske cannabis brand and the Alchemist nutraceutical brand. To differentiate his companies from the rest of the marketplace, he systematically developed a portfolio of brands...
Billy Prim, Chariman of Primo Water (Nasdaq:PRMW) talks about being authentic and attracting the right board members.
Welcome to a special edition of “What’s Next?” In this episode, you’ll hear CoreNet Global's CEO, Angela Cain, and Chariman, David Kamen, discuss the benefits of mentoring at our 2018 global summit in Madrid, Spain. The opinions expressed in What's Next podcasts are not necessarily those of CoreNet Global.
Kim Lorimier, Chair of the Democratic Party of Indian River County ********************************************* “YOU CANT GO BACK AND CHANGE THE BEGINNING BUT YOU CAN START WHERE YOU ARE AND CHANGE THE ENDING.The Yak About Today broadcasts deliver on air and online conversations, interviews and stories engaging the Baby Boomer Generation and beyond with discussions, tips and information. Hosted by an authentic conversationalist, intuitive listener and a boomer himself, David Yakir brings a genuine, down to earth and disarming personality that talks with his audience and his guests with out talking at them. David shares #Engagement, #Education, #Enjoyment & #Empowerment on air and online for the #BabyBoomer Generation delivered with #humor, #wit and #thought. Yak About Today is your GPS guide for #technology, #fitness, #automotive, #finance #entrepreneurship, #entrepreneurship & all things that mean anything to you. For more information, visit: http://yakirgroup.com/ http://facebook.com/yakabouttoday/ http://twitter.com/yakabouttoday/ #baby-boomer #health #yakabouttoday #davidyakir #iheartradio #seniors #davidyakirgroup #marketing #Baby-boomer-sponsers #newvisioneyecenter #spreaker #ivook #itunes #blubrry #boomers #vero Beach, #babyboomer-finance, #politics
From the Ruger booth at the 2018 NRA Annual Meetings, Tom talks with representatives from Silencer Shop, Springfield Armory, Timney Triggers, and James Dickey, Chariman of the Republican Party of Texas. Tom Gresham's Gun Talk®, 5.13.18 Hour 2
This is the first in a series of podcasts where we're aggregating multiple conversations with different world class direct selling executives around a single topic and this one is about technological unemployment, an idea that AI, automation and robotics are beginning to take away more jobs than they create. This is a phenomenon that is transforming the future of how people work. In this conversation you'll hear from: Traci Lynn, Founder & CEO of Traci Lynn Jewelry Al Bala, CEO of Mannatech Mark 'Bouncer' Schiro, Chariman of Stream Energy Jared Richards, Former President of Jamberry Kris Shenk, CIO of CAbi
In this episode Wendy interviews Jim Hale, U.S. Veteran and Chariman of the Mental Health Consumer Council and The Veterans Voices Advisory Board in Fayetteville Arkansas. Sponsored by Total Hemp and Better Living Rx.
The Empire Club of Canada Presents: Annual Investment Outlook Luncheon 2018 featuring: Ian Russell, CEO, Investment Industry Association of Canada; David Rosenberg, Chief Economist, Gluskin, Sheff & Assoicates Inc.; Nick Barisheff, President and CEO, BMG Group Inc. Ian C.W. Russell: Ian Russell is President and Chief Executive Officer of the Investment Industry Association of Canada, a position he has held since its inauguration in April 2006. Prior to his appointment at IIAC, Mr. Russell headed the Industry Relations and Representation group of the Investment Dealers Association of Canada. In his 20-year tenure at the Association, he has participated actively in many committees and working groups involved in regulatory and tax issues related to the securities industry and capital markets in Canada. He is a frequent columnist in industry publications and is a presenter and speaker on industry issues and developments. This past June, Mr. Russell was appointed Chariman of the Standing Committee on Regulatory Affairs at the International Council of Securities Associations (ICSA). Mr. Russell has an honours degree in economics and business from the University of Western Ontario, and a postgraduate degree from the London School of Economics. He has completed the Partners, Directors and Officers Qualification Examination and is a Fellow of the Canadian Securities Institute. David Rosenberg: Mr. Rosenberg is the Firm's Chief Economist & Strategist with a focus on providing a top-down perspective to the Firm's investment process and Asset Mix Committee. Mr. Rosenberg received both a Bachelor of Arts and Masters of Arts degree in Economics from the University of Toronto. Prior to joining Gluskin Sheff in the spring of 2009, Mr. Rosenberg was Chief North American Economist at Merrill Lynch in New York for seven years, during which he was consistently ranked in the Institutional Investor All-Star analyst rankings. Prior thereto, he was Chief Economist and Strategist for Merrill Lynch Canada, based out of Toronto. Mr. Rosenberg is also the author of Breakfast with Dave, a daily distillation of his economic and financial market insights. Nick Barisheff: Nick Barisheff is the founder, president and CEO of BMG Group Inc., a company dedicated to providing investors with a secure, cost-effective, transparent way to purchase and hold physical bullion. BMG is an Associate Member of the London Bullion Market Association (LBMA), an Associate Member of the Responsible Investment Association (RIA) and signatory to the Principles for Responsible Investment (PRI). Widely recognized as international bullion expert, Nick has written numerous articles on bullion and current market trends that have been published on various news and business websites. Nick has appeared on BNN, CBC, CNBC and Sun Media, and has been interviewed for countless articles by leading business publications across North America, Europe and Asia... Speakers: Ian Russell, President and Chief Executive Officer, Investment Industry Association of Canada David Rosenberg, Chief Economist, Gluskin Sheff +Associates Inc. Nick Barisheff, President and Chief Executive Officer, BMG Group Inc. *The content presented is free of charge but please note that the Empire Club of Canada retains copyright. Neither the speeches themselves nor any part of their content may be used for any purpose other than personal interest or research without the explicit permission of the Empire Club of Canada.* *Views and Opinions Expressed Disclaimer: The views and opinions expressed by the speakers or panelists are those of the speakers or panelists and do not necessarily reflect or represent the official views and opinions, policy or position held by The Empire Club of Canada.*
Welcome back to another episode of Cage Side Submissions,Brought to you by Future Legend Apperal We plan to provide you with unique and fun-filled SHOWS. News, highlights, and interviews Please feel free to call in with your questions and comments at anytime. 657-383-0267 For our Host Steve Rychel (@CSSRadio) Our First Guest is Chariman and CEO of Maverick MMA Willy Sisca (@MaverickMMA1) And Our Final guest is Lightweight Steve McCabe Steve is set to step back into the Cage April 7th against Scott Heckman at the Sherman Theater in Stroudsburg,Pa
Gary Ginsberg is a semi-retired attorney-at-law practicing for nearly 60 years! Aaron and Gary first discuss the myriad responsibilities Gary has held and how working as a lawyer pointed him in so many different directions. After describing exactly what a Chairman of the Board is, Gary then chats about growing cacti and succulents without once mistakenly calling them cactuses. He has ruled over many businesses but Gary’s true dominion is over his plants. Learn about how time management pays off and be inspired by Gary’s amazing work ethic! Please subscribe to this podcast in iTunes or your favorite Podcast app so you never miss an episode! Follow us: Twitter @ButIAlso Instagram @ButIAlso Facebook: www.facebook.com/ButIAlso
Today’s guest, Randy Nelson, is CEO of Gold Dolphins, LLC author of "The Second Decision: The Qualified Entrepreneur.” It’s a wonderful book that has changed the way I lead my own business. The first decision is your decision to start a business. The titular Second Decision comes in after the business is up and running smoothly. The Second Decision is whether or not you, as a Founder of a business, are the right person to run a business. The book helps you answer the question, “Am I the right person to lead this company for the next 3-5 years?” Randy defines five roles in the book – three are qualified to help run a business and two are not. The Leader is the person who is at CEO and wants to be the person to lead the company’s future. The Role Player is the person who doesn’t want to lead the company but has their own expertise, and they might fill a position like Chariman of the board. The Creator is the person who loves getting businesses off the ground, they’re a startup person, but they aren’t passionate about running a business. The Dabbler is the person who wants cash but isn’t interesting in learning everything they need to learn to build a business. Status Quo is the person who is happy where they are at. Randy models his qualification system around the tests he went through to become a submarine pilot. It features a qualification card that asks you every question anyone will need to be able to answer to run a business for the foreseeable future, built around the top reasons companies fail or underperform. “I really am pushing leaders for self-awareness on whether they are the right person in that right seat. It's a combination of self-confidence and self-awareness. If you have both, it's a powerful combo. If it's just the self-confidence piece without the self-awareness, it’s a risk.” Randy wants leaders reading the book to be more self-aware of the role they are best at and enjoy the most. It’s okay if you aren’t the leader and don’t have a role to play in running a stable company – you just have to be self-aware enough to hire someone better suited for that role or leave the company behind. Randy is currently working on “The Third Decision,” which will explore how leaders and entrepreneurs can avoid some regrets in their lives by being more self aware of the decisions they make in their personal lives. If you haven’t already, pick up "The Second Decision: The Qualified Entrepreneur" and become more self-aware about the role you should have in your business. It’s a must buy. Resources: "The Second Decision: The Qualified Entrepreneur” by Randy Nelson Learn more about Randy and Leadership on www.randyhnelson.com Production & Development for Improv Is No Joke by Podcast Masters Learn more about your ad choices. Visit megaphone.fm/adchoices
On location this week lapping up the festive fayre, Caroline Barker and Dave Watters are joined by Nick Robinson, Chairman of the Isthmian League, Mark Harris, Chairman of the Northern Premier League and Brian Barwick, Chariman of the Northern League.
Ruby talks about Girls Rock! Melbourne a fab event in January for 12-17-y-o female and non-binary aspiring musos; Chariman of the 3 CR Board James McKenzie drops by and toes crossed for no paracite and yes to birth certifcate reforms passing this week.
A former Chairman of Citigroup and former CEO of AOL Time Warner, Dick Parsons has tackled some of the toughest jobs of any American corporate executive in the past 25 years. In this episode of Fortune Unfiltered, Parsons explains why he’s always the person who gets called after disaster strikes. “I’m attracted to that – it keeps your attention,” Parsons says of leading in a crisis. “ It concentrates the mind as Pat Moynihan used to say. If you’ve got serious issues you need to be alert [and] alive in the moment. I’m not the world’s best steady-state manager...not a particularly good one because my mind wanders.” In addition to the AOL and Citigroup jobs, Parsons took over as interim CEO of the NBA’s Los Angeles Clippers in May 2014 amid the Donald Sterling scandal. But all those professional tribulations pale in comparison to the battle Parsons is fighting today. About two years ago he was diagnosed with multiple myeloma, a blood cancer for which there are a variety of treatments but currently no cure. Parsons talks frankly about his battle with cancer, his management philosophy and his reflections on being one of the first African-Americans to run a Fortune 500 company.
Leadership Expert and Author of 8 Bestselling Books, Justin Sachs. One More Sale Path to Mastery Justin Sachs is a highly- acclaimed business and marketing expert who has educated and inspired over eleven million people worldwide on how to more powerfully connect with their target market, reach their prospects, create marketing systems, and increase their customer and brand loyalty. Having been acknowledged by US Presidents, Congressmen, and World-Renowned Business Leaders, Justin’s strategic consulting is called on by some of the world’s leading corporations and brands. “Through your service to others, you demonstrate the outstanding character of America and help strengthen our country.” -Hon. George W. Bush, 43rd President of the United States of America “Your efforts will leave a lasting impression on countless individuals, and I thank you for your hard work.” – Hon. Arnold Schwarzenegger, California State Governor He has been featured in hundreds of media outlets throughout the world including CBS Radio, MSNBC, CNBC, Fox News, ABC and Yahoo Finance. Justin’s industry leading publishing company, Motivational Press was recognized in 2014 on the INC 500 list as one of the fastest growing companies and the 4th fastest growing media company in the world. Motivational Press has published some of the world’s leading experts on business, personal-development, and health & wellness including Brian Tracy, Jack Canfield, Tony Alessandra, Barry Moltz and more. His media relations company, Expert Media Relations has secured his clients media appearances across every major media outlet including CNN, FOX, NBC, CBS, Oprah, Good Morning America, and more. “Thank you for your inspiring commitment to serving your community. Contributions like yours make our communities and our entire nation stronger.” -Arthur Ryan, Chariman and CEO of Prudential Financial Sachs, a philanthropist from the start, has won many awards and accolades for serving his community including the Prudential Spirit of Community Award, and Distinguished Recognition from the California Department of Education. He has been honored to partner with organizations like Kiva, Hugh O’Brian Youth Leadership Foundation, and The Illumination Foundation. “I am pleased to recognize Justin Sachs for his dedication… Your outstanding leadership is commendable.” –Hon. Gavin Newsom, Lt. Governor of California and Fmr. Mayor of San Francisco, California Justin’s books and DVDs have been read by hundreds of thousands worldwide. Justin’s Books: Skyrocket: Your Sales, Your Business, Your Life – 2014 Justin has had 8 best-selling books: Customer Loyalty—2013 — International Best-Seller — Over 20,000 copies sold Customer Loyalty provides the world’s leading tools, strategies, and principles from the world’s leading strategic business professionals. These are the systems and practices real world entrepreneurs and business leaders are using every day in their businesses to increase their customer loyalty and the overall lifetime value of their customers. Ultimate Marketing Mastery -2013 Master the tools strategies and principles provided by some of the worlds leading authorities on Marketing, Public Relations, Social Media and more. These are the tools and strategies that have been executed by small businesses and Fortune 500 companies to produce significant revenue. How to Publish Your Book – 2013 — International Best-Seller — Over 10,000 copies sold How to Publish Your Book gives you the tools, strategies and systems you need to master and implement in order to successfully enter the book industry. Best-selling author and publisher, Justin Sachs, shares his insider secrets having published over 250 products and consulted with world-renowned personal development authority, Anthony Robbins, and co-author of Chicken Soup for the Soul Series, Mark Victor Hansen. This book is a must-read for anyone looking to release a book. One-Minute Team Building – 2011 — International Best-Seller — Over 17,500 copies sold One-Minute Team Building features excerpts written by the foremost experts in corporate, non-profit, and community team building. It includes simple tools, strategies, and principles leaders can use to most effectively build their teams to improve productivity, maximize results and enhance overall success. The systems provided to you in One-Minute Team building provide you everything you need to know to build your teams with the social proof and real-world examples of its implementation so you have a one-stop-shop for peak performance team development. It is a must read for anyone looking to empower, unite, and motivate the members of their team Ultimate Business Mastery – 2011– International Best-Seller — Over 27,300 copies sold Ultimate Business Mastery gives entrepreneurs and business owners the tools and strategies they need to Maximize Your Productivity, Increase Your Revenue, and Achieve Your Highest Level of Influence. Power of Philanthropy – 2010 — International Best-Seller — Over 36,000 copies sold Partnerships built with international non-profit organizations. The Power of Philanthropy is a collection of stories that represent the most extraordinary individuals who are contributing at the highest levels in making a bold difference in the world. It includes stories of non-profit organizations, corporations, entrepreneurs and more who all have one thing in common: their commitment to being of service to others has made a measurable difference in the lives of many. Power of Persistence – 2009 — — International Best-Seller — Over 58,000 copies sold The Power of Persistence contains the most uplifting and impacting stories of how persistence has shaped the greatest leaders in business and life in general. Ever wonder what the difference is between those who have enormous success and those who just barely make it by? This book will show you why persistence is the number one skill the greatest successes have. Your Mailbox Is Full – Real Teens In the Real World – 2008 — — International Best-Seller — Over 24,000 copies sold — Partnerships with International Non-Profit Organizations. Your Mailbox is Full is a teen development book which gives teens the life-skills and leadership development principles teenagers need to be successful in high school, college and throughout their lives. . It teaches the most important tools needed to take your life to the next level. Together, We ll Accomplish These Results: Greater Self-Esteem to Overcome Peer Pressure Power to Set Motivating and Exciting Goals A Passion for Contribution A Positive Outlook on Life A Clear Vision of One s Life Plan A Positive and Motivating Role Model for Today s Youth The Feeling of Being In Charge of Your Destiny Increases Productivity in Both School and Extracurricular Activities Enhanced Leadership Development To Live Life More Energized and Motivated.
In this episode of Greatland's Small Business Success, we learn about...MONEY! We all want it and we all need more of it. Find out how to keep track of your money from Greg Jones, Founder and Chariman of Bookkeeping Express. Plus a very special Start Up Story about one of America's favorite games.
The Empire Club of Canada Presents: Investment Outlook 2014 featuring Ian Russell, Nick Barisheff and Andre Philippe Hardy lan Russell is President and Chief Executive Officer of the Investment Industry Association of Canada, a position he has held since its inauguration in April 2006. Prior to his appointment at IIAC, Mr. Russell headed the Industry Relations and Representation group of the Investment Dealers Association of Canada. In his 20 year tenure at the Association, he has participated actively in many committees and working groups involved in regulatory and tax issues related to the securities industry and capital markets in Canada. He is a frequent columnist in industry publications and is a presenter and speaker on industry issues and developments. This past June, Mr. Russell was appointed Chariman of the Standing Committee on Regulatory Affairs at the International Council of Securities Associations, ICSA. Mr. Russell has an honours degree in economics and business from the University of Western Ontario, and a postgraduate degree from the London School of Economics. He has completed the Partners, Directors and Officers Qualification Examination and is a Fellow of the Canadian Securities Institute. Nick Barisheff is the founder, president and CEO of Bullion Management Group Inc., a company dedicated to providing investors with a secure, cost effective, transparent way to purchase and hold physical bullion. BMG is an Associate Member of the London Bullion Market Association, LBMA, as well as the Social Investment Organization, SIO. Widely recognized as international bullion expert, Nick has written numerous articles on bullion and current market trends, which have been published on various news and business websites. Nick has appeared on BNN, CBC, CNBC and Sun Media, and has been interviewed for countless articles by leading business publications across North America, Europe and Asia. His first book $10,000 Gold: Why Gold's Inevitable Rise is the Investors Safe Haven, was published in the Spring of 2013. Every investor who seeks the safety of sound money will benefit from Nick's insights into the portfolio preserving power of gold. Andre Philippe Hardy is Head of Canadian Research at RBC Capital Markets, an investment bank that provides a focused set of products and services to corporations, institutional investors and governments around the world. Prior to assuming his current position in November 2013, Andre led RBC Capital Markets Canadian financial services Equity Research team for six years, with direct coverage of banks and insurance companies. Throughout his career as an equity analyst, Andre was ranked consistently as a top analyst in his sectors in industry surveys, while his stock-picking success was validated by his StarMine rankings and his work was often quoted in the financial press. His primers on banking and insurance were unique products, which were widely read by investors as well as management teams. Andre joined RBC Capital Markets in 2007 after ... Speakers: Ian Russell, President and Chief Executive Officer of the Investment Industry Association of Canada Nick Barisheff, President and CEO of Bullion Management Group Inc. Andre Philippe Hardy, Head of Canadian Research at RBC Capital Markets *The content presented is free of charge but please note that the Empire Club of Canada retains copyright. Neither the speeches themselves nor any part of their content may be used for any purpose other than personal interest or research without the explicit permission of the Empire Club of Canada.* *Views and Opinions Expressed Disclaimer: The views and opinions expressed by the speakers or panelists are those of the speakers or panelists and do not necessarily reflect or represent the official views and opinions, policy or position held by The Empire Club of Canada.*
Host GARY HOLT welcomes former Chariman of Back Country Horsemen of America ALAN HILL as we talk about the challenges faced in maintaining trail use for all horsemen. R W HAMPTON joins us for the "Campfire Cafe" to share his Award Winning Music and Life on the Range CAROLE MERCER author, horsewoman and 2013 nominee to the National Cowgirl Musem and Hall of Fame will share tales of her life as an Oregon cowgirl. Grab a cup of coffee and join us for an amazing show to kick off a great month on EQUESTRIAN LEGACY RADIO!
Mo Ibrahim, Chariman and Founder, Mo Ibrahim Foundation and Founder of Celtel International, on what we can learn from emerging markets. The Global Leadership Summit is the London Business School's flagship event for its global community. http://www.london.edu
Mo Ibrahim, Chariman and Founder, Mo Ibrahim Foundation and Founder of Celtel International, on what we can learn from emerging markets. The Global Leadership Summit is the London Business School's flagship event for its global community. http://www.london.edu
Home insulation from an Asian Perspective - the feasibility, the cost and the benefits in terms of energy and ringgit saves.See omnystudio.com/listener for privacy information.
Host: Jerry Johnson Guest: Dr. Ted Baehr, Christian movie critic, publisher of Movieguide”, and Chariman of the Christian Film and Television Commission.
© 2020-2025 Ivy Podcast Discovery LLC
